#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.ConceptLayer|identifier


1-1	0-7	Altered	_
1-2	8-17	intrinsic	_
1-3	18-21	and	_
1-4	22-31	extrinsic	_
1-5	32-44	connectivity	_
1-6	45-47	in	_
1-7	48-61	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
1-8	62-75	Schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
1-9	76-78	is	_
1-10	79-80	a	_
1-11	81-89	disorder	_
1-12	90-103	characterized	_
1-13	104-106	by	_
1-14	107-117	functional	_
1-15	118-133	dysconnectivity	_
1-16	134-139	among	_
1-17	140-151	distributed	_
1-18	152-157	brain	_
1-19	158-165	regions	_
1-20	166-167	.	_

2-1	168-175	However	_
2-2	176-177	,	_
2-3	178-180	it	_
2-4	181-183	is	_
2-5	184-191	unclear	_
2-6	192-195	how	_
2-7	196-202	causal	_
2-8	203-213	influences	_
2-9	214-219	among	_
2-10	220-231	large-scale	_
2-11	232-237	brain	_
2-12	238-246	networks	_
2-13	247-250	are	_
2-14	251-260	disrupted	_
2-15	261-263	in	_
2-16	264-277	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
2-17	278-279	.	_

3-1	280-282	In	_
3-2	283-287	this	_
3-3	288-293	study	_
3-4	294-295	,	_
3-5	296-298	we	_
3-6	299-303	used	_
3-7	304-311	dynamic	_
3-8	312-318	causal	_
3-9	319-327	modeling	_
3-10	328-329	(	_
3-11	330-333	DCM	_
3-12	334-335	)	_
3-13	336-338	to	_
3-14	339-345	assess	_
3-15	346-349	the	_
3-16	350-360	hypothesis	_
3-17	361-365	that	_
3-18	366-371	there	_
3-19	372-374	is	_
3-20	375-383	aberrant	_
3-21	384-392	directed	_
3-22	393-394	(	_
3-23	395-404	effective	_
3-24	405-406	)	_
3-25	407-419	connectivity	_
3-26	420-426	within	_
3-27	427-430	and	_
3-28	431-438	between	_
3-29	439-444	three	_
3-30	445-448	key	_
3-31	449-460	large-scale	_
3-32	461-466	brain	_
3-33	467-475	networks	_
3-34	476-477	(	_
3-35	478-481	the	_
3-36	482-488	dorsal	_
3-37	489-498	attention	_
3-38	499-506	network	_
3-39	507-508	,	_
3-40	509-512	the	_
3-41	513-521	salience	_
3-42	522-529	network	_
3-43	530-533	and	_
3-44	534-537	the	_
3-45	538-545	default	_
3-46	546-550	mode	_
3-47	551-558	network	_
3-48	559-560	)	_
3-49	561-563	in	_
3-50	564-577	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
3-51	578-584	during	_
3-52	585-586	a	_
3-53	587-594	working	_
3-54	595-601	memory	_
3-55	602-606	task	_
3-56	607-608	.	_

4-1	609-619	Functional	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
4-2	620-623	MRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
4-3	624-628	data	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
4-4	629-635	during	_
4-5	636-638	an	_
4-6	639-645	n-back	http://maven.renci.org/NeuroBridge/neurobridge#BackTaskTest
4-7	646-650	task	http://maven.renci.org/NeuroBridge/neurobridge#BackTaskTest
4-8	651-655	from	_
4-9	656-658	40	_
4-10	659-667	patients	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
4-11	668-672	with	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
4-12	673-686	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
4-13	687-690	and	_
4-14	691-693	62	_
4-15	694-701	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
4-16	702-710	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
4-17	711-715	were	_
4-18	716-724	analyzed	_
4-19	725-726	.	_

5-1	727-732	Using	_
5-2	733-745	hierarchical	_
5-3	746-754	modeling	_
5-4	755-757	of	_
5-5	758-773	between-subject	_
5-6	774-781	effects	_
5-7	782-784	in	_
5-8	785-788	DCM	_
5-9	789-793	with	_
5-10	794-804	Parametric	_
5-11	805-814	Empirical	_
5-12	815-820	Bayes	_
5-13	821-822	,	_
5-14	823-825	we	_
5-15	826-831	found	_
5-16	832-836	that	_
5-17	837-846	intrinsic	_
5-18	847-848	(	_
5-19	849-862	within-region	_
5-20	863-864	)	_
5-21	865-868	and	_
5-22	869-878	extrinsic	_
5-23	879-880	(	_
5-24	881-895	between-region	_
5-25	896-897	)	_
5-26	898-907	effective	_
5-27	908-920	connectivity	_
5-28	921-930	involving	_
5-29	931-941	prefrontal	_
5-30	942-949	regions	_
5-31	950-954	were	_
5-32	955-963	abnormal	_
5-33	964-966	in	_
5-34	967-980	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
5-35	981-982	.	_

6-1	983-995	Specifically	_
6-2	996-997	,	_
6-3	998-1000	in	_
6-4	1001-1009	patients	_
6-5	1010-1011	(	_
6-6	1012-1013	i	_
6-7	1014-1015	)	_
6-8	1016-1026	inhibitory	_
6-9	1027-1043	self-connections	_
6-10	1044-1046	in	_
6-11	1047-1057	prefrontal	_
6-12	1058-1065	regions	_
6-13	1066-1068	of	_
6-14	1069-1072	the	_
6-15	1073-1079	dorsal	_
6-16	1080-1089	attention	_
6-17	1090-1097	network	_
6-18	1098-1102	were	_
6-19	1103-1112	decreased	_
6-20	1113-1119	across	_
6-21	1120-1124	task	_
6-22	1125-1135	conditions	_
6-23	1136-1137	;	_
6-24	1138-1139	(	_
6-25	1140-1142	ii	_
6-26	1143-1144	)	_
6-27	1145-1154	extrinsic	_
6-28	1155-1167	connectivity	_
6-29	1168-1175	between	_
6-30	1176-1183	regions	_
6-31	1184-1186	of	_
6-32	1187-1190	the	_
6-33	1191-1198	default	_
6-34	1199-1203	mode	_
6-35	1204-1211	network	_
6-36	1212-1215	was	_
6-37	1216-1225	increased	_
6-38	1226-1227	;	_
6-39	1228-1240	specifically	_
6-40	1241-1242	,	_
6-41	1243-1247	from	_
6-42	1248-1257	posterior	_
6-43	1258-1267	cingulate	_
6-44	1268-1274	cortex	_
6-45	1275-1277	to	_
6-46	1278-1281	the	_
6-47	1282-1288	medial	_
6-48	1289-1299	prefrontal	_
6-49	1300-1306	cortex	_
6-50	1307-1308	;	_
6-51	1309-1310	(	_
6-52	1311-1314	iii	_
6-53	1315-1316	)	_
6-54	1317-1332	between-network	_
6-55	1333-1342	extrinsic	_
6-56	1343-1354	connections	_
6-57	1355-1364	involving	_
6-58	1365-1368	the	_
6-59	1369-1379	prefrontal	_
6-60	1380-1386	cortex	_
6-61	1387-1391	were	_
6-62	1392-1399	altered	_
6-63	1400-1401	;	_
6-64	1402-1403	(	_
6-65	1404-1406	iv	_
6-66	1407-1408	)	_
6-67	1409-1420	connections	_
6-68	1421-1427	within	_
6-69	1428-1436	networks	_
6-70	1437-1440	and	_
6-71	1441-1448	between	_
6-72	1449-1457	networks	_
6-73	1458-1462	were	_
6-74	1463-1473	correlated	_
6-75	1474-1478	with	_
6-76	1479-1482	the	_
6-77	1483-1491	severity	_
6-78	1492-1494	of	_
6-79	1495-1503	clinical	_
6-80	1504-1512	symptoms	_
6-81	1513-1516	and	_
6-82	1517-1525	impaired	_
6-83	1526-1535	cognition	_
6-84	1536-1542	beyond	_
6-85	1543-1550	working	_
6-86	1551-1557	memory	_
6-87	1558-1559	.	_

7-1	1560-1562	In	_
7-2	1563-1568	short	_
7-3	1569-1570	,	_
7-4	1571-1575	this	_
7-5	1576-1581	study	_
7-6	1582-1590	revealed	_
7-7	1591-1594	the	_
7-8	1595-1607	predominance	_
7-9	1608-1610	of	_
7-10	1611-1618	reduced	_
7-11	1619-1627	synaptic	_
7-12	1628-1636	efficacy	_
7-13	1637-1639	of	_
7-14	1640-1650	prefrontal	_
7-15	1651-1660	efferents	_
7-16	1661-1664	and	_
7-17	1665-1674	afferents	_
7-18	1675-1677	in	_
7-19	1678-1681	the	_
7-20	1682-1697	pathophysiology	_
7-21	1698-1700	of	_
7-22	1701-1714	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
7-23	1715-1716	.	_

8-1	1717-1727	Highlights	_
8-2	1728-1729	A	_
8-3	1730-1735	first	_
8-4	1736-1739	use	_
8-5	1740-1742	of	_
8-6	1743-1755	hierarchical	_
8-7	1756-1764	modeling	_
8-8	1765-1767	of	_
8-9	1768-1777	effective	_
8-10	1778-1790	connectivity	_
8-11	1791-1793	to	_
8-12	1794-1806	characterize	_
8-13	1807-1818	large-scale	_
8-14	1819-1827	networks	_
8-15	1828-1830	in	_
8-16	1831-1844	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
8-17	1845-1846	.	_

9-1	1847-1856	Intrinsic	_
9-2	1857-1860	and	_
9-3	1861-1870	extrinsic	_
9-4	1871-1880	effective	_
9-5	1881-1893	connectivity	_
9-6	1894-1903	involving	_
9-7	1904-1914	prefrontal	_
9-8	1915-1922	regions	_
9-9	1923-1927	were	_
9-10	1928-1936	abnormal	_
9-11	1937-1939	in	_
9-12	1940-1953	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
9-13	1954-1955	.	_

10-1	1956-1966	Diagnostic	_
10-2	1967-1978	connections	_
10-3	1979-1984	could	_
10-4	1985-1992	predict	_
10-5	1993-1996	the	_
10-6	1997-2005	severity	_
10-7	2006-2008	of	_
10-8	2009-2017	clinical	_
10-9	2018-2026	symptoms	_
10-10	2027-2030	and	_
10-11	2031-2040	cognition	_
10-12	2041-2043	in	_
10-13	2044-2057	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
10-14	2058-2059	.	_

11-1	2060-2069	Materials	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
11-2	2070-2073	and	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
11-3	2074-2081	methods	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
11-4	2082-2094	Participants	_
11-5	2095-2103	Patients	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
11-6	2104-2108	with	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
11-7	2109-2122	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
11-8	2123-2127	were	_
11-9	2128-2137	recruited	_
11-10	2138-2142	from	_
11-11	2143-2146	the	_
11-12	2147-2157	Department	_
11-13	2158-2160	of	_
11-14	2161-2171	Psychiatry	_
11-15	2172-2173	,	_
11-16	2174-2180	Renmin	_
11-17	2181-2189	Hospital	_
11-18	2190-2192	of	_
11-19	2193-2198	Wuhan	_
11-20	2199-2209	University	_
11-21	2210-2211	(	_
11-22	2212-2217	Wuhan	_
11-23	2218-2219	,	_
11-24	2220-2225	China	_
11-25	2226-2227	)	_
11-26	2228-2229	.	_

12-1	2230-2233	The	_
12-2	2234-2244	Structured	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewfortheDiagnosticStatisticalManualofMentalDisorder
12-3	2245-2253	Clinical	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewfortheDiagnosticStatisticalManualofMentalDisorder
12-4	2254-2263	Interview	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewfortheDiagnosticStatisticalManualofMentalDisorder
12-5	2264-2267	for	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewfortheDiagnosticStatisticalManualofMentalDisorder
12-6	2268-2271	the	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewfortheDiagnosticStatisticalManualofMentalDisorder
12-7	2272-2282	Diagnostic	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewfortheDiagnosticStatisticalManualofMentalDisorder
12-8	2283-2286	and	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewfortheDiagnosticStatisticalManualofMentalDisorder
12-9	2287-2298	Statistical	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewfortheDiagnosticStatisticalManualofMentalDisorder
12-10	2299-2305	Manual	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewfortheDiagnosticStatisticalManualofMentalDisorder
12-11	2306-2308	of	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewfortheDiagnosticStatisticalManualofMentalDisorder
12-12	2309-2315	Mental	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewfortheDiagnosticStatisticalManualofMentalDisorder
12-13	2316-2324	Disorder	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewfortheDiagnosticStatisticalManualofMentalDisorder
12-14	2325-2326	,	_
12-15	2327-2330	4th	_
12-16	2331-2338	edition	_
12-17	2339-2340	(	_
12-18	2341-2347	DSM-IV	_
12-19	2348-2349	)	_
12-20	2350-2351	(	_
12-21	2352-2356	SCID	_
12-22	2357-2358	)	_
12-23	2359-2362	was	_
12-24	2363-2375	administered	_
12-25	2376-2377	,	_
12-26	2378-2380	to	_
12-27	2381-2388	confirm	_
12-28	2389-2398	diagnosis	_
12-29	2399-2400	.	_

13-1	2401-2404	The	_
13-2	2405-2413	patients	_
13-3	2414-2418	also	_
13-4	2419-2422	met	_
13-5	2423-2426	the	_
13-6	2427-2436	following	_
13-7	2437-2446	inclusion	_
13-8	2447-2455	criteria	_
13-9	2456-2457	:	_
13-10	2458-2459	(	_
13-11	2460-2461	1	_
13-12	2462-2463	)	_
13-13	2464-2467	the	_
13-14	2468-2473	total	_
13-15	2474-2479	score	_
13-16	2480-2482	of	_
13-17	2483-2491	Positive	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
13-18	2492-2495	and	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
13-19	2496-2504	Negative	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
13-20	2505-2513	Syndrome	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
13-21	2514-2519	Scale	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
13-22	2520-2521	(	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
13-23	2522-2527	PANSS	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
13-24	2528-2529	)	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
13-25	2530-2533	was	_
13-26	2534-2538	over	_
13-27	2539-2541	60	_
13-28	2542-2543	,	_
13-29	2544-2545	(	_
13-30	2546-2547	2	_
13-31	2548-2549	)	_
13-32	2550-2558	duration	_
13-33	2559-2561	of	_
13-34	2562-2569	illness	_
13-35	2570-2573	was	_
13-36	2574-2575	<	_
13-37	2576-2577	5	_
13-38	2578-2583	years	_
13-39	2584-2585	,	_
13-40	2586-2587	(	_
13-41	2588-2589	3	_
13-42	2590-2591	)	_
13-43	2592-2597	18–45	_
13-44	2598-2603	years	_
13-45	2604-2606	of	_
13-46	2607-2610	age	_
13-47	2611-2612	,	_
13-48	2613-2614	(	_
13-49	2615-2616	4	_
13-50	2617-2618	)	_
13-51	2619-2621	at	_
13-52	2622-2627	least	_
13-53	2628-2629	9	_
13-54	2630-2635	years	_
13-55	2636-2638	of	_
13-56	2639-2648	education	_
13-57	2649-2650	,	_
13-58	2651-2652	(	_
13-59	2653-2654	5	_
13-60	2655-2656	)	_
13-61	2657-2669	right-handed	_
13-62	2670-2671	,	_
13-63	2672-2675	and	_
13-64	2676-2677	(	_
13-65	2678-2679	6	_
13-66	2680-2681	)	_
13-67	2682-2685	Han	_
13-68	2686-2693	Chinese	_
13-69	2694-2695	.	_

14-1	2696-2704	Patients	_
14-2	2705-2709	were	_
14-3	2710-2718	excluded	_
14-4	2719-2721	if	_
14-5	2722-2726	they	_
14-6	2727-2730	met	_
14-7	2731-2734	the	_
14-8	2735-2744	diagnosis	_
14-9	2745-2753	criteria	_
14-10	2754-2756	of	_
14-11	2757-2760	any	_
14-12	2761-2766	other	_
14-13	2767-2770	DSM	_
14-14	2771-2777	Axis-I	_
14-15	2778-2787	disorders	_
14-16	2788-2789	,	_
14-17	2790-2793	had	_
14-18	2794-2800	severe	_
14-19	2801-2809	physical	_
14-20	2810-2817	illness	_
14-21	2818-2827	including	_
14-22	2828-2842	cardiovascular	_
14-23	2843-2850	disease	_
14-24	2851-2852	,	_
14-25	2853-2856	had	_
14-26	2857-2865	received	_
14-27	2866-2883	electroconvulsive	_
14-28	2884-2891	therapy	_
14-29	2892-2895	six	_
14-30	2896-2902	months	_
14-31	2903-2908	prior	_
14-32	2909-2911	to	_
14-33	2912-2923	recruitment	_
14-34	2924-2925	,	_
14-35	2926-2928	or	_
14-36	2929-2932	had	_
14-37	2933-2943	structural	_
14-38	2944-2951	changes	_
14-39	2952-2954	in	_
14-40	2955-2958	the	_
14-41	2959-2964	brain	_
14-42	2965-2966	(	_
14-43	2967-2971	such	_
14-44	2972-2974	as	_
14-45	2975-2976	a	_
14-46	2977-2982	white	_
14-47	2983-2989	matter	_
14-48	2990-2996	lesion	_
14-49	2997-2998	)	_
14-50	2999-3008	diagnosed	_
14-51	3009-3011	by	_
14-52	3012-3013	a	_
14-53	3014-3025	radiologist	_
14-54	3026-3027	.	_

15-1	3028-3035	Healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
15-2	3036-3044	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
15-3	3045-3049	were	_
15-4	3050-3059	recruited	_
15-5	3060-3062	by	_
15-6	3063-3067	word	_
15-7	3068-3070	of	_
15-8	3071-3076	mouth	_
15-9	3077-3080	and	_
15-10	3081-3089	bulletin	_
15-11	3090-3095	board	_
15-12	3096-3104	postings	_
15-13	3105-3109	both	_
15-14	3110-3112	in	_
15-15	3113-3116	the	_
15-16	3117-3125	hospital	_
15-17	3126-3129	and	_
15-18	3130-3136	nearby	_
15-19	3137-3148	communities	_
15-20	3149-3150	.	_

16-1	3151-3154	The	_
16-2	3155-3162	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
16-3	3163-3171	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
16-4	3172-3173	,	_
16-5	3174-3177	who	_
16-6	3178-3185	matched	_
16-7	3186-3189	the	_
16-8	3190-3198	patients	_
16-9	3199-3201	on	_
16-10	3202-3205	age	_
16-11	3206-3207	,	_
16-12	3208-3214	gender	_
16-13	3215-3218	and	_
16-14	3219-3230	educational	_
16-15	3231-3236	level	_
16-16	3237-3238	,	_
16-17	3239-3242	had	_
16-18	3243-3246	the	_
16-19	3247-3251	same	_
16-20	3252-3261	inclusion	_
16-21	3262-3265	and	_
16-22	3266-3275	exclusion	_
16-23	3276-3284	criteria	_
16-24	3285-3286	;	_
16-25	3287-3293	except	_
16-26	3294-3298	that	_
16-27	3299-3306	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
16-28	3307-3315	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
16-29	3316-3320	were	_
16-30	3321-3329	excluded	_
16-31	3330-3332	if	_
16-32	3333-3337	they	_
16-33	3338-3340	or	_
16-34	3341-3346	their	_
16-35	3347-3362	first-relatives	_
16-36	3363-3366	met	_
16-37	3367-3370	any	_
16-38	3371-3380	diagnosis	_
16-39	3381-3383	of	_
16-40	3384-3385	a	_
16-41	3386-3397	psychiatric	_
16-42	3398-3406	disorder	_
16-43	3407-3416	according	_
16-44	3417-3419	to	_
16-45	3420-3423	the	_
16-46	3424-3430	DSM-IV	_
16-47	3431-3439	criteria	_
16-48	3440-3441	.	_

17-1	3442-3451	Fifty-one	_
17-2	3452-3460	patients	_
17-3	3461-3464	and	_
17-4	3465-3467	66	_
17-5	3468-3475	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
17-6	3476-3484	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
17-7	3485-3489	were	_
17-8	3490-3499	recruited	_
17-9	3500-3501	.	_

18-1	3502-3505	All	_
18-2	3506-3509	the	_
18-3	3510-3518	patients	_
18-4	3519-3523	were	_
18-5	3524-3533	receiving	_
18-6	3534-3547	antipsychotic	_
18-7	3548-3559	medications	_
18-8	3560-3561	,	_
18-9	3562-3567	which	_
18-10	3568-3572	were	_
18-11	3573-3582	converted	_
18-12	3583-3585	to	_
18-13	3586-3591	their	_
18-14	3592-3606	chlorpromazine	_
18-15	3607-3618	equivalents	_
18-16	3619-3620	.	_

19-1	3621-3624	Six	_
19-2	3625-3633	patients	_
19-3	3634-3637	and	_
19-4	3638-3639	4	_
19-5	3640-3647	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
19-6	3648-3656	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
19-7	3657-3661	were	_
19-8	3662-3670	excluded	_
19-9	3671-3675	from	_
19-10	3676-3679	the	_
19-11	3680-3684	data	_
19-12	3685-3693	analyses	_
19-13	3694-3697	due	_
19-14	3698-3700	to	_
19-15	3701-3707	severe	_
19-16	3708-3712	head	_
19-17	3713-3719	motion	_
19-18	3720-3726	during	_
19-19	3727-3735	scanning	_
19-20	3736-3737	(	_
19-21	3738-3739	x	_
19-22	3740-3741	,	_
19-23	3742-3743	y	_
19-24	3744-3745	,	_
19-25	3746-3747	z	_
19-26	3748-3759	translation	_
19-27	3760-3761	>	_
19-28	3762-3763	3	_
19-29	3764-3766	mm	_
19-30	3767-3769	or	_
19-31	3770-3771	x	_
19-32	3772-3773	,	_
19-33	3774-3775	y	_
19-34	3776-3777	,	_
19-35	3778-3779	z	_
19-36	3780-3788	rotation	_
19-37	3789-3790	>	_
19-38	3791-3793	3°	_
19-39	3794-3795	)	_
19-40	3796-3797	,	_
19-41	3798-3799	3	_
19-42	3800-3808	patients	_
19-43	3809-3813	were	_
19-44	3814-3822	excluded	_
19-45	3823-3826	due	_
19-46	3827-3829	to	_
19-47	3830-3839	extremely	_
19-48	3840-3844	high	_
19-49	3845-3851	values	_
19-50	3852-3854	in	_
19-51	3855-3858	the	_
19-52	3859-3863	mean	_
19-53	3864-3869	frame	_
19-54	3870-3882	displacement	_
19-55	3883-3884	(	_
19-56	3885-3887	FD	_
19-57	3888-3889	)	_
19-58	3890-3895	value	_
19-59	3896-3899	and	_
19-60	3900-3901	2	_
19-61	3902-3910	patients	_
19-62	3911-3915	were	_
19-63	3916-3924	excluded	_
19-64	3925-3928	due	_
19-65	3929-3931	to	_
19-66	3932-3939	extreme	_
19-67	3940-3943	low	_
19-68	3944-3950	scores	_
19-69	3951-3953	in	_
19-70	3954-3957	the	_
19-71	3958-3964	0-back	_
19-72	3965-3976	performance	_
19-73	3977-3978	(	_
19-74	3979-3982	see	_
19-75	3983-3990	details	_
19-76	3991-3993	in	_
19-77	3994-4005	Methodology	_
19-78	4006-4007	)	_
19-79	4008-4009	.	_

20-1	4010-4017	Finally	_
20-2	4018-4019	,	_
20-3	4020-4022	40	_
20-4	4023-4031	patients	_
20-5	4032-4035	and	_
20-6	4036-4038	62	_
20-7	4039-4045	normal	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
20-8	4046-4054	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
20-9	4055-4059	were	_
20-10	4060-4068	included	_
20-11	4069-4071	in	_
20-12	4072-4075	the	_
20-13	4076-4085	following	_
20-14	4086-4090	data	_
20-15	4091-4099	analyses	_
20-16	4100-4101	.	_

21-1	4102-4106	Each	_
21-2	4107-4118	participant	_
21-3	4119-4121	or	_
21-4	4122-4124	at	_
21-5	4125-4130	least	_
21-6	4131-4134	one	_
21-7	4135-4147	first-degree	_
21-8	4148-4156	relative	_
21-9	4157-4160	for	_
21-10	4161-4165	each	_
21-11	4166-4173	patient	_
21-12	4174-4182	provided	_
21-13	4183-4191	informed	_
21-14	4192-4199	consent	_
21-15	4200-4206	before	_
21-16	4207-4220	participation	_
21-17	4221-4222	.	_

22-1	4223-4226	The	_
22-2	4227-4233	Ethics	_
22-3	4234-4243	Committee	_
22-4	4244-4246	of	_
22-5	4247-4253	Renmin	_
22-6	4254-4262	Hospital	_
22-7	4263-4265	of	_
22-8	4266-4271	Wuhan	_
22-9	4272-4282	University	_
22-10	4283-4286	and	_
22-11	4287-4290	the	_
22-12	4291-4304	Institutional	_
22-13	4305-4311	Review	_
22-14	4312-4317	Board	_
22-15	4318-4320	of	_
22-16	4321-4324	the	_
22-17	4325-4334	Institute	_
22-18	4335-4337	of	_
22-19	4338-4348	Psychology	_
22-20	4349-4350	,	_
22-21	4351-4358	Chinese	_
22-22	4359-4366	Academy	_
22-23	4367-4369	of	_
22-24	4370-4378	Sciences	_
22-25	4379-4387	approved	_
22-26	4388-4391	the	_
22-27	4392-4397	study	_
22-28	4398-4399	.	_

23-1	4400-4412	Experimental	_
23-2	4413-4419	design	_
23-3	4420-4423	and	_
23-4	4424-4428	task	_
23-5	4429-4432	The	_
23-6	4433-4435	WM	http://maven.renci.org/NeuroBridge/neurobridge#SternbergItemRecognitionParadigmTask
23-7	4436-4444	paradigm	http://maven.renci.org/NeuroBridge/neurobridge#SternbergItemRecognitionParadigmTask
23-8	4445-4449	used	_
23-9	4450-4451	a	_
23-10	4452-4459	blocked	_
23-11	4460-4466	design	_
23-12	4467-4468	,	_
23-13	4469-4476	numeric	_
23-14	4477-4483	n-back	_
23-15	4484-4488	task	http://maven.renci.org/NeuroBridge/neurobridge#BackTaskTest
23-16	4489-4490	,	_
23-17	4491-4495	with	_
23-18	4496-4503	numbers	_
23-19	4504-4507	0–9	_
23-20	4508-4510	as	_
23-21	4511-4518	stimuli	_
23-22	4519-4520	,	_
23-23	4521-4526	which	_
23-24	4527-4530	has	_
23-25	4531-4535	been	_
23-26	4536-4540	used	_
23-27	4541-4543	in	_
23-28	4544-4552	previous	_
23-29	4553-4560	studies	_
23-30	4561-4562	.	_

24-1	4563-4566	The	_
24-2	4567-4575	paradigm	_
24-3	4576-4586	alternated	_
24-4	4587-4594	between	_
24-5	4595-4599	rest	_
24-6	4600-4603	and	_
24-7	4604-4608	task	_
24-8	4609-4610	.	_

25-1	4611-4615	Rest	_
25-2	4616-4623	periods	_
25-3	4624-4625	,	_
25-4	4626-4628	in	_
25-5	4629-4634	which	_
25-6	4635-4643	subjects	_
25-7	4644-4648	were	_
25-8	4649-4659	instructed	_
25-9	4660-4662	to	_
25-10	4663-4669	fixate	_
25-11	4670-4672	on	_
25-12	4673-4674	a	_
25-13	4675-4680	cross	_
25-14	4681-4683	at	_
25-15	4684-4687	the	_
25-16	4688-4694	centre	_
25-17	4695-4697	of	_
25-18	4698-4701	the	_
25-19	4702-4708	screen	_
25-20	4709-4710	,	_
25-21	4711-4717	lasted	_
25-22	4718-4721	for	_
25-23	4722-4723	5	_
25-24	4724-4729	scans	_
25-25	4730-4731	(	_
25-26	4732-4735	i.e	_
25-27	4736-4737	.	_

26-1	4738-4740	10	_
26-2	4741-4742	s	_
26-3	4743-4744	)	_
26-4	4745-4746	.	_

27-1	4747-4750	The	_
27-2	4751-4755	task	_
27-3	4756-4765	consisted	_
27-4	4766-4768	of	_
27-5	4769-4772	two	_
27-6	4773-4783	conditions	_
27-7	4784-4785	,	_
27-8	4786-4792	0-back	_
27-9	4793-4794	(	_
27-10	4795-4803	baseline	_
27-11	4804-4805	)	_
27-12	4806-4809	and	_
27-13	4810-4816	2-back	_
27-14	4817-4818	(	_
27-15	4819-4821	WM	_
27-16	4822-4826	load	_
27-17	4827-4836	condition	_
27-18	4837-4838	)	_
27-19	4839-4840	,	_
27-20	4841-4849	arranged	_
27-21	4850-4852	as	_
27-22	4853-4876	0-2-0-0-2-2-2-0-0-2-2-0	_
27-23	4877-4878	,	_
27-24	4879-4883	each	_
27-25	4884-4888	with	_
27-26	4889-4897	duration	_
27-27	4898-4900	of	_
27-28	4901-4903	12	_
27-29	4904-4909	scans	_
27-30	4910-4911	(	_
27-31	4912-4915	i.e	_
27-32	4916-4917	.	_

28-1	4918-4920	24	_
28-2	4921-4922	s	_
28-3	4923-4924	)	_
28-4	4925-4926	.	_

29-1	4927-4933	Before	_
29-2	4934-4938	each	_
29-3	4939-4944	block	_
29-4	4945-4946	a	_
29-5	4947-4953	visual	_
29-6	4954-4957	cue	_
29-7	4958-4960	of	_
29-8	4961-4964	one	_
29-9	4965-4969	scan	_
29-10	4970-4971	(	_
29-11	4972-4975	i.e	_
29-12	4976-4977	.	_

30-1	4978-4979	2	_
30-2	4980-4981	s	_
30-3	4982-4983	)	_
30-4	4984-4987	was	_
30-5	4988-4997	presented	_
30-6	4998-4999	,	_
30-7	5000-5010	indicating	_
30-8	5011-5014	the	_
30-9	5015-5024	condition	_
30-10	5025-5027	of	_
30-11	5028-5031	the	_
30-12	5032-5042	subsequent	_
30-13	5043-5048	block	_
30-14	5049-5050	.	_

31-1	5051-5055	Each	_
31-2	5056-5061	block	_
31-3	5062-5071	comprised	_
31-4	5072-5074	12	_
31-5	5075-5082	stimuli	_
31-6	5083-5084	,	_
31-7	5085-5090	three	_
31-8	5091-5093	of	_
31-9	5094-5099	which	_
31-10	5100-5104	were	_
31-11	5105-5112	targets	_
31-12	5113-5114	,	_
31-13	5115-5119	each	_
31-14	5120-5129	presented	_
31-15	5130-5133	for	_
31-16	5134-5138	1000	_
31-17	5139-5141	ms	_
31-18	5142-5146	with	_
31-19	5147-5148	a	_
31-20	5149-5153	1000	_
31-21	5154-5156	ms	_
31-22	5157-5170	interstimulus	_
31-23	5171-5179	interval	_
31-24	5180-5181	.	_

32-1	5182-5190	Subjects	_
32-2	5191-5195	were	_
32-3	5196-5206	instructed	_
32-4	5207-5209	to	_
32-5	5210-5215	match	_
32-6	5216-5219	the	_
32-7	5220-5227	current	_
32-8	5228-5234	number	_
32-9	5235-5237	to	_
32-10	5238-5239	a	_
32-11	5240-5246	target	_
32-12	5247-5248	,	_
32-13	5249-5255	either	_
32-14	5256-5259	the	_
32-15	5260-5266	number	_
32-16	5267-5268	9	_
32-17	5269-5270	(	_
32-18	5271-5277	0-back	_
32-19	5278-5279	)	_
32-20	5280-5282	or	_
32-21	5283-5286	the	_
32-22	5287-5293	number	_
32-23	5294-5303	presented	_
32-24	5304-5307	two	_
32-25	5308-5314	trials	_
32-26	5315-5322	earlier	_
32-27	5323-5324	(	_
32-28	5325-5331	2-back	_
32-29	5332-5333	)	_
32-30	5334-5335	.	_

33-1	5336-5338	In	_
33-2	5339-5344	order	_
33-3	5345-5347	to	_
33-4	5348-5354	ensure	_
33-5	5355-5365	compliance	_
33-6	5366-5372	during	_
33-7	5373-5376	the	_
33-8	5377-5387	subsequent	_
33-9	5388-5399	acquisition	_
33-10	5400-5401	,	_
33-11	5402-5403	a	_
33-12	5404-5412	training	_
33-13	5413-5420	session	_
33-14	5421-5424	was	_
33-15	5425-5434	conducted	_
33-16	5435-5440	prior	_
33-17	5441-5443	to	_
33-18	5444-5452	scanning	_
33-19	5453-5454	.	_

34-1	5455-5458	The	_
34-2	5459-5467	training	_
34-3	5468-5477	procedure	_
34-4	5478-5481	was	_
34-5	5482-5485	the	_
34-6	5486-5490	same	_
34-7	5491-5493	as	_
34-8	5494-5498	that	_
34-9	5499-5503	used	_
34-10	5504-5506	in	_
34-11	5507-5510	our	_
34-12	5511-5519	previous	_
34-13	5520-5525	study	_
34-14	5526-5527	.	_

35-1	5528-5530	In	_
35-2	5531-5536	brief	_
35-3	5537-5538	,	_
35-4	5539-5542	the	_
35-5	5543-5551	training	_
35-6	5552-5556	task	_
35-7	5557-5560	was	_
35-8	5561-5568	similar	_
35-9	5569-5571	to	_
35-10	5572-5575	the	_
35-11	5576-5582	formal	_
35-12	5583-5587	task	_
35-13	5588-5589	,	_
35-14	5590-5596	though	_
35-15	5597-5601	only	_
35-16	5602-5605	one	_
35-17	5606-5612	0-back	_
35-18	5613-5616	and	_
35-19	5617-5620	one	_
35-20	5621-5627	2-back	_
35-21	5628-5633	trial	_
35-22	5634-5638	were	_
35-23	5639-5647	included	_
35-24	5648-5649	.	_

36-1	5650-5658	Accuracy	_
36-2	5659-5662	was	_
36-3	5663-5672	displayed	_
36-4	5673-5675	on	_
36-5	5676-5679	the	_
36-6	5680-5687	monitor	_
36-7	5688-5690	at	_
36-8	5691-5694	the	_
36-9	5695-5698	end	_
36-10	5699-5701	of	_
36-11	5702-5705	the	_
36-12	5706-5714	practice	_
36-13	5715-5719	task	_
36-14	5720-5721	,	_
36-15	5722-5725	and	_
36-16	5726-5734	patients	_
36-17	5735-5739	were	_
36-18	5740-5748	provided	_
36-19	5749-5753	with	_
36-20	5754-5761	further	_
36-21	5762-5770	practice	_
36-22	5771-5784	opportunities	_
36-23	5785-5786	,	_
36-24	5787-5792	until	_
36-25	5793-5797	they	_
36-26	5798-5805	clearly	_
36-27	5806-5816	understood	_
36-28	5817-5820	the	_
36-29	5821-5825	task	_
36-30	5826-5827	.	_

37-1	5828-5837	Cognition	_
37-2	5838-5849	assessments	_
37-3	5850-5857	Several	_
37-4	5858-5867	cognitive	_
37-5	5868-5879	assessments	_
37-6	5880-5884	were	_
37-7	5885-5894	conducted	_
37-8	5895-5902	outside	_
37-9	5903-5905	of	_
37-10	5906-5914	scanning	_
37-11	5915-5916	.	_

38-1	5917-5922	These	_
38-2	5923-5931	included	_
38-3	5932-5935	the	_
38-4	5936-5941	Digit	http://maven.renci.org/NeuroBridge/neurobridge#DigitSymbolSubstitutionOfTheWechslerAdultIntelligenceScaleRevised
38-5	5942-5948	Symbol	http://maven.renci.org/NeuroBridge/neurobridge#DigitSymbolSubstitutionOfTheWechslerAdultIntelligenceScaleRevised
38-6	5949-5955	Coding	http://maven.renci.org/NeuroBridge/neurobridge#DigitSymbolSubstitutionOfTheWechslerAdultIntelligenceScaleRevised
38-7	5956-5960	task	http://maven.renci.org/NeuroBridge/neurobridge#DigitSymbolSubstitutionOfTheWechslerAdultIntelligenceScaleRevised
38-8	5961-5962	,	_
38-9	5963-5968	Digit	http://maven.renci.org/NeuroBridge/neurobridge#DigitSymbolSubstitutionOfTheWechslerAdultIntelligenceScaleRevised
38-10	5969-5973	Span	http://maven.renci.org/NeuroBridge/neurobridge#DigitSymbolSubstitutionOfTheWechslerAdultIntelligenceScaleRevised
38-11	5974-5975	(	_
38-12	5976-5983	forward	_
38-13	5984-5987	and	_
38-14	5988-5996	backward	_
38-15	5997-5998	)	_
38-16	5999-6002	and	_
38-17	6003-6011	Category	_
38-18	6012-6019	Fluency	http://maven.renci.org/NeuroBridge/neurobridge#VerbalFluencyTask
38-19	6020-6024	test	http://maven.renci.org/NeuroBridge/neurobridge#VerbalFluencyTask
38-20	6025-6026	.	_

39-1	6027-6030	The	_
39-2	6031-6036	Digit	http://maven.renci.org/NeuroBridge/neurobridge#DigitSymbolSubstitutionOfTheWechslerAdultIntelligenceScaleRevised
39-3	6037-6043	Symbol	http://maven.renci.org/NeuroBridge/neurobridge#DigitSymbolSubstitutionOfTheWechslerAdultIntelligenceScaleRevised
39-4	6044-6050	Coding	http://maven.renci.org/NeuroBridge/neurobridge#DigitSymbolSubstitutionOfTheWechslerAdultIntelligenceScaleRevised
39-5	6051-6055	task	http://maven.renci.org/NeuroBridge/neurobridge#DigitSymbolSubstitutionOfTheWechslerAdultIntelligenceScaleRevised
39-6	6056-6064	assesses	_
39-7	6065-6076	information	_
39-8	6077-6087	processing	_
39-9	6088-6093	speed	_
39-10	6094-6097	and	_
39-11	6098-6100	is	_
39-12	6101-6106	known	_
39-13	6107-6109	to	_
39-14	6110-6116	detect	_
39-15	6117-6128	impairments	_
39-16	6129-6131	in	_
39-17	6132-6145	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
39-18	6146-6154	reliably	_
39-19	6155-6156	.	_

40-1	6157-6160	The	_
40-2	6161-6169	Category	_
40-3	6170-6177	Fluency	_
40-4	6178-6182	test	_
40-5	6183-6185	is	_
40-6	6186-6189	the	_
40-7	6190-6199	cognitive	_
40-8	6200-6210	assessment	_
40-9	6211-6215	with	_
40-10	6216-6219	the	_
40-11	6220-6226	second	_
40-12	6227-6234	largest	_
40-13	6235-6241	effect	_
40-14	6242-6246	size	_
40-15	6247-6248	,	_
40-16	6249-6257	followed	_
40-17	6258-6260	by	_
40-18	6261-6264	the	_
40-19	6265-6270	Digit	http://maven.renci.org/NeuroBridge/neurobridge#DigitSymbolSubstitutionOfTheWechslerAdultIntelligenceScaleRevised
40-20	6271-6277	Symbol	http://maven.renci.org/NeuroBridge/neurobridge#DigitSymbolSubstitutionOfTheWechslerAdultIntelligenceScaleRevised
40-21	6278-6284	Coding	http://maven.renci.org/NeuroBridge/neurobridge#DigitSymbolSubstitutionOfTheWechslerAdultIntelligenceScaleRevised
40-22	6285-6289	task	http://maven.renci.org/NeuroBridge/neurobridge#DigitSymbolSubstitutionOfTheWechslerAdultIntelligenceScaleRevised
40-23	6290-6291	.	_

41-1	6292-6295	The	_
41-2	6296-6301	Digit	_
41-3	6302-6306	Span	_
41-4	6307-6308	(	_
41-5	6309-6316	forward	_
41-6	6317-6320	and	_
41-7	6321-6329	backward	_
41-8	6330-6331	)	_
41-9	6332-6334	is	_
41-10	6335-6336	a	_
41-11	6337-6344	general	_
41-12	6345-6355	assessment	_
41-13	6356-6358	of	_
41-14	6359-6368	attention	_
41-15	6369-6372	and	_
41-16	6373-6380	working	_
41-17	6381-6387	memory	_
41-18	6388-6396	capacity	_
41-19	6397-6398	.	_

42-1	6399-6402	MRI	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
42-2	6403-6407	data	_
42-3	6408-6419	acquisition	_
42-4	6420-6423	and	_
42-5	6424-6437	preprocessing	_
42-6	6438-6441	MRI	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
42-7	6442-6446	data	_
42-8	6447-6451	were	_
42-9	6452-6460	acquired	_
42-10	6461-6465	from	_
42-11	6466-6469	the	_
42-12	6470-6479	Radiology	_
42-13	6480-6490	Department	_
42-14	6491-6493	of	_
42-15	6494-6500	Renmin	_
42-16	6501-6509	Hospital	_
42-17	6510-6512	of	_
42-18	6513-6518	Wuhan	_
42-19	6519-6529	University	_
42-20	6530-6534	with	_
42-21	6535-6536	a	_
42-22	6537-6544	General	_
42-23	6545-6553	Electric	_
42-24	6554-6558	HDxt	_
42-25	6559-6563	3.0T	_
42-26	6564-6571	Scanner	_
42-27	6572-6573	.	_

43-1	6574-6585	Whole-brain	http://maven.renci.org/NeuroBridge/neurobridge#DegenerativeBrainDisorder
43-2	6586-6596	functional	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
43-3	6597-6602	scans	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
43-4	6603-6607	were	_
43-5	6608-6617	collected	_
43-6	6618-6620	in	_
43-7	6621-6623	32	_
43-8	6624-6629	axial	_
43-9	6630-6636	slices	_
43-10	6637-6642	using	_
43-11	6643-6645	an	_
43-12	6646-6657	echo-planar	http://maven.renci.org/NeuroBridge/neurobridge#MolecularImaging
43-13	6658-6665	imaging	http://maven.renci.org/NeuroBridge/neurobridge#MolecularImaging
43-14	6666-6667	(	http://maven.renci.org/NeuroBridge/neurobridge#MolecularImaging
43-15	6668-6671	EPI	http://maven.renci.org/NeuroBridge/neurobridge#MolecularImaging
43-16	6672-6673	)	http://maven.renci.org/NeuroBridge/neurobridge#MolecularImaging
43-17	6674-6682	sequence	http://maven.renci.org/NeuroBridge/neurobridge#MolecularImaging
43-18	6683-6684	(	_
43-19	6685-6695	repetition	_
43-20	6696-6700	time	_
43-21	6701-6702	=	_
43-22	6703-6707	2000	_
43-23	6708-6710	ms	_
43-24	6711-6712	,	_
43-25	6713-6717	echo	_
43-26	6718-6722	time	_
43-27	6723-6724	=	_
43-28	6725-6727	30	_
43-29	6728-6730	ms	_
43-30	6731-6732	;	_
43-31	6733-6737	flip	_
43-32	6738-6743	angle	_
43-33	6744-6745	=	_
43-34	6746-6749	90°	_
43-35	6750-6751	;	_
43-36	6752-6758	matrix	_
43-37	6759-6760	=	_
43-38	6761-6763	64	_
43-39	6764-6765	×	_
43-40	6766-6768	64	_
43-41	6769-6770	;	_
43-42	6771-6776	field	_
43-43	6777-6779	of	_
43-44	6780-6784	view	_
43-45	6785-6786	=	_
43-46	6787-6790	220	_
43-47	6791-6793	mm	_
43-48	6794-6795	×	_
43-49	6796-6799	220	_
43-50	6800-6802	mm	_
43-51	6803-6804	;	_
43-52	6805-6810	slice	_
43-53	6811-6820	thickness	_
43-54	6821-6822	=	_
43-55	6823-6824	4	_
43-56	6825-6827	mm	_
43-57	6828-6829	;	_
43-58	6830-6833	and	_
43-59	6834-6839	slice	_
43-60	6840-6843	gap	_
43-61	6844-6845	=	_
43-62	6846-6849	0.6	_
43-63	6850-6852	mm	_
43-64	6853-6854	)	_
43-65	6855-6856	.	_

44-1	6857-6867	Anatomical	http://maven.renci.org/NeuroBridge/neurobridge#StructuralImaging
44-2	6868-6874	images	http://maven.renci.org/NeuroBridge/neurobridge#StructuralImaging
44-3	6875-6879	were	_
44-4	6880-6888	acquired	_
44-5	6889-6894	using	_
44-6	6895-6896	a	_
44-7	6897-6912	high-resolution	http://maven.renci.org/NeuroBridge/neurobridge#HighRisk
44-8	6913-6924	T1-weighted	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
44-9	6925-6933	sequence	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
44-10	6934-6935	(	_
44-11	6936-6946	repetition	_
44-12	6947-6951	time	_
44-13	6952-6953	=	_
44-14	6954-6957	7.8	_
44-15	6958-6960	ms	_
44-16	6961-6962	;	_
44-17	6963-6967	echo	_
44-18	6968-6972	time	_
44-19	6973-6974	=	_
44-20	6975-6978	3.0	_
44-21	6979-6981	ms	_
44-22	6982-6983	;	_
44-23	6984-6988	flip	_
44-24	6989-6994	angle	_
44-25	6995-6996	=	_
44-26	6997-6999	7°	_
44-27	7000-7001	;	_
44-28	7002-7008	matrix	_
44-29	7009-7010	=	_
44-30	7011-7014	256	_
44-31	7015-7016	×	_
44-32	7017-7020	256	_
44-33	7021-7022	;	_
44-34	7023-7028	field	_
44-35	7029-7031	of	_
44-36	7032-7036	view	_
44-37	7037-7038	=	_
44-38	7039-7042	256	_
44-39	7043-7044	×	_
44-40	7045-7048	256	_
44-41	7049-7052	mm2	_
44-42	7053-7054	;	_
44-43	7055-7060	slice	_
44-44	7061-7070	thickness	_
44-45	7071-7072	=	_
44-46	7073-7074	1	_
44-47	7075-7077	mm	_
44-48	7078-7079	)	_
44-49	7080-7088	composed	_
44-50	7089-7091	of	_
44-51	7092-7095	188	_
44-52	7096-7102	slices	_
44-53	7103-7105	in	_
44-54	7106-7107	a	_
44-55	7108-7116	sagittal	_
44-56	7117-7128	orientation	_
44-57	7129-7130	.	_

45-1	7131-7138	Initial	_
45-2	7139-7144	image	_
45-3	7145-7158	preprocessing	_
45-4	7159-7162	was	_
45-5	7163-7172	performed	_
45-6	7173-7178	using	_
45-7	7179-7190	Statistical	_
45-8	7191-7201	Parametric	_
45-9	7202-7209	Mapping	_
45-10	7210-7211	(	_
45-11	7212-7217	SPM12	_
45-12	7218-7219	)	_
45-13	7220-7221	(	_
45-14	7222-7226	http	_
45-15	7227-7228	:	_
45-16	7229-7257	//www.fil.ion.ucl.ac.uk/spm/	_
45-17	7258-7259	)	_
45-18	7260-7263	and	_
45-19	7264-7272	included	_
45-20	7273-7278	slice	_
45-21	7279-7285	timing	_
45-22	7286-7296	correction	_
45-23	7297-7298	,	_
45-24	7299-7305	motion	_
45-25	7306-7316	correction	_
45-26	7317-7318	,	_
45-27	7319-7329	structural	_
45-28	7330-7333	and	_
45-29	7334-7344	functional	_
45-30	7345-7350	image	_
45-31	7351-7366	co-registration	_
45-32	7367-7368	,	_
45-33	7369-7381	segmentation	_
45-34	7382-7383	,	_
45-35	7384-7397	normalization	_
45-36	7398-7399	(	_
45-37	7400-7405	based	_
45-38	7406-7408	on	_
45-39	7409-7413	each	_
45-40	7414-7425	participant	_
45-41	7426-7428	's	_
45-42	7429-7439	structural	_
45-43	7440-7445	image	_
45-44	7446-7447	)	_
45-45	7448-7450	to	_
45-46	7451-7454	the	_
45-47	7455-7463	Montreal	_
45-48	7464-7476	Neurological	_
45-49	7477-7486	Institute	_
45-50	7487-7488	(	_
45-51	7489-7492	MNI	_
45-52	7493-7494	)	_
45-53	7495-7498	152	_
45-54	7499-7507	template	_
45-55	7508-7509	,	_
45-56	7510-7513	and	_
45-57	7514-7523	smoothing	_
45-58	7524-7529	using	_
45-59	7530-7531	a	_
45-60	7532-7538	kernel	_
45-61	7539-7543	with	_
45-62	7544-7545	a	_
45-63	7546-7556	full-width	_
45-64	7557-7561	half	_
45-65	7562-7569	maximum	_
45-66	7570-7572	of	_
45-67	7573-7574	6	_
45-68	7575-7577	mm	_
45-69	7578-7579	.	_

46-1	7580-7583	The	_
46-2	7584-7594	normalized	_
46-3	7595-7601	images	_
46-4	7602-7606	were	_
46-5	7607-7619	interpolated	_
46-6	7620-7622	to	_
46-7	7623-7624	a	_
46-8	7625-7635	resolution	_
46-9	7636-7638	of	_
46-10	7639-7640	3	_
46-11	7641-7642	×	_
46-12	7643-7644	3	_
46-13	7645-7646	×	_
46-14	7647-7648	3	_
46-15	7649-7652	mm3	_
46-16	7653-7654	.	_

47-1	7655-7666	Furthermore	_
47-2	7667-7668	,	_
47-3	7669-7674	based	_
47-4	7675-7677	on	_
47-5	7678-7681	the	_
47-6	7682-7686	head	_
47-7	7687-7693	motion	_
47-8	7694-7704	parameters	_
47-9	7705-7713	obtained	_
47-10	7714-7719	after	_
47-11	7720-7731	realignment	_
47-12	7732-7733	,	_
47-13	7734-7736	we	_
47-14	7737-7745	computed	_
47-15	7746-7749	the	_
47-16	7750-7762	volume-based	_
47-17	7763-7773	frame-wise	_
47-18	7774-7786	displacement	_
47-19	7787-7788	(	_
47-20	7789-7791	FD	_
47-21	7792-7793	)	_
47-22	7794-7796	to	_
47-23	7797-7805	quantify	_
47-24	7806-7810	head	_
47-25	7811-7817	motion	_
47-26	7818-7819	.	_

48-1	7820-7830	Behavioral	_
48-2	7831-7839	analysis	_
48-3	7840-7842	To	_
48-4	7843-7849	assess	_
48-5	7850-7860	behavioral	_
48-6	7861-7872	performance	_
48-7	7873-7875	of	_
48-8	7876-7879	the	_
48-9	7880-7886	n-back	_
48-10	7887-7891	task	_
48-11	7892-7893	,	_
48-12	7894-7897	the	_
48-13	7898-7909	sensitivity	_
48-14	7910-7915	index	_
48-15	7916-7917	,	_
48-16	7918-7920	d′	_
48-17	7921-7925	from	_
48-18	7926-7932	signal	_
48-19	7933-7942	detection	_
48-20	7943-7949	theory	_
48-21	7950-7953	was	_
48-22	7954-7958	used	_
48-23	7959-7960	.	_

49-1	7961-7964	The	_
49-2	7965-7970	score	_
49-3	7971-7973	d′	_
49-4	7974-7983	describes	_
49-5	7984-7995	sensitivity	_
49-6	7996-7997	;	_
49-7	7998-8002	i.e.	_
49-8	8003-8004	,	_
49-9	8005-8008	the	_
49-10	8009-8016	ability	_
49-11	8017-8019	to	_
49-12	8020-8028	separate	_
49-13	8029-8035	signal	_
49-14	8036-8037	(	_
49-15	8038-8039	“	_
49-16	8040-8044	true	_
49-17	8045-8046	”	_
49-18	8047-8053	events	_
49-19	8054-8055	)	_
49-20	8056-8059	and	_
49-21	8060-8065	noise	_
49-22	8066-8067	(	_
49-23	8068-8069	“	_
49-24	8070-8075	false	_
49-25	8076-8077	”	_
49-26	8078-8084	events	_
49-27	8085-8086	)	_
49-28	8087-8088	.	_

50-1	8089-8092	The	_
50-2	8093-8098	score	_
50-3	8099-8102	was	_
50-4	8103-8111	computed	_
50-5	8112-8122	separately	_
50-6	8123-8126	for	_
50-7	8127-8133	0-back	_
50-8	8134-8143	condition	_
50-9	8144-8147	and	_
50-10	8148-8154	2-back	_
50-11	8155-8164	condition	_
50-12	8165-8166	(	_
50-13	8167-8170	d′0	_
50-14	8171-8174	and	_
50-15	8175-8178	d′2	_
50-16	8179-8180	)	_
50-17	8181-8184	for	_
50-18	8185-8189	each	_
50-19	8190-8201	participant	_
50-20	8202-8203	.	_

51-1	8204-8205	A	_
51-2	8206-8214	repeated	_
51-3	8215-8223	measures	_
51-4	8224-8229	ANOVA	_
51-5	8230-8234	with	_
51-6	8235-8245	conditions	_
51-7	8246-8248	as	_
51-8	8249-8261	within-group	_
51-9	8262-8268	factor	_
51-10	8269-8272	and	_
51-11	8273-8282	diagnosis	_
51-12	8283-8285	as	_
51-13	8286-8299	between-group	_
51-14	8300-8306	factor	_
51-15	8307-8310	was	_
51-16	8311-8320	conducted	_
51-17	8321-8326	using	_
51-18	8327-8331	SPSS	_
51-19	8332-8336	20.0	_
51-20	8337-8338	.	_

52-1	8339-8342	Two	_
52-2	8343-8349	sample	_
52-3	8350-8357	t-tests	_
52-4	8358-8362	were	_
52-5	8363-8367	used	_
52-6	8368-8370	to	_
52-7	8371-8377	assess	_
52-8	8378-8383	group	_
52-9	8384-8395	differences	_
52-10	8396-8398	in	_
52-11	8399-8402	the	_
52-12	8403-8408	Digit	_
52-13	8409-8415	Symbol	_
52-14	8416-8422	Coding	_
52-15	8423-8427	task	_
52-16	8428-8429	,	_
52-17	8430-8435	Digit	_
52-18	8436-8440	Span	http://maven.renci.org/NeuroBridge/neurobridge#BackTaskTest
52-19	8441-8445	task	http://maven.renci.org/NeuroBridge/neurobridge#BackTaskTest
52-20	8446-8449	and	_
52-21	8450-8458	Category	_
52-22	8459-8466	Fluency	_
52-23	8467-8471	task	_
52-24	8472-8473	.	_

53-1	8474-8477	GLM	_
53-2	8478-8486	analysis	_
53-3	8487-8488	A	_
53-4	8489-8496	general	_
53-5	8497-8503	linear	_
53-6	8504-8509	model	_
53-7	8510-8511	(	_
53-8	8512-8515	GLM	_
53-9	8516-8517	)	_
53-10	8518-8521	was	_
53-11	8522-8533	constructed	_
53-12	8534-8538	with	_
53-13	8539-8549	regressors	_
53-14	8550-8553	for	_
53-15	8554-8558	each	_
53-16	8559-8561	of	_
53-17	8562-8565	the	_
53-18	8566-8569	two	_
53-19	8570-8574	task	_
53-20	8575-8585	conditions	_
53-21	8586-8587	(	_
53-22	8588-8594	0-back	_
53-23	8595-8598	and	_
53-24	8599-8605	2-back	_
53-25	8606-8607	)	_
53-26	8608-8610	as	_
53-27	8611-8615	well	_
53-28	8616-8618	as	_
53-29	8619-8622	the	_
53-30	8623-8634	instruction	_
53-31	8635-8639	cues	_
53-32	8640-8643	for	_
53-33	8644-8647	the	_
53-34	8648-8652	task	_
53-35	8653-8659	blocks	_
53-36	8660-8661	.	_

54-1	8662-8664	To	_
54-2	8665-8672	regress	_
54-3	8673-8676	out	_
54-4	8677-8683	motion	_
54-5	8684-8687	and	_
54-6	8688-8701	physiological	_
54-7	8702-8707	noise	_
54-8	8708-8709	(	_
54-9	8710-8714	e.g.	_
54-10	8715-8716	,	_
54-11	8717-8719	of	_
54-12	8720-8727	cardiac	_
54-13	8728-8731	and	_
54-14	8732-8743	respiratory	_
54-15	8744-8750	origin	_
54-16	8751-8752	)	_
54-17	8753-8754	,	_
54-18	8755-8765	additional	_
54-19	8766-8776	covariates	_
54-20	8777-8781	were	_
54-21	8782-8790	included	_
54-22	8791-8793	to	_
54-23	8794-8799	model	_
54-24	8800-8801	:	_
54-25	8802-8803	(	_
54-26	8804-8805	1	_
54-27	8806-8807	)	_
54-28	8808-8811	six	_
54-29	8812-8816	head	_
54-30	8817-8823	motion	_
54-31	8824-8834	parameters	_
54-32	8835-8843	obtained	_
54-33	8844-8846	by	_
54-34	8847-8852	rigid	_
54-35	8853-8857	body	_
54-36	8858-8862	head	_
54-37	8863-8869	motion	_
54-38	8870-8880	correction	_
54-39	8881-8884	and	_
54-40	8885-8886	(	_
54-41	8887-8888	2	_
54-42	8889-8890	)	_
54-43	8891-8895	five	_
54-44	8896-8905	principal	_
54-45	8906-8916	components	_
54-46	8917-8921	from	_
54-47	8922-8924	an	_
54-48	8925-8937	anatomically	_
54-49	8938-8945	defined	_
54-50	8946-8951	noise	_
54-51	8952-8955	VOI	_
54-52	8956-8957	(	_
54-53	8958-8966	composed	_
54-54	8967-8969	of	_
54-55	8970-8975	white	_
54-56	8976-8982	matter	_
54-57	8983-8986	and	_
54-58	8987-9000	cerebrospinal	_
54-59	9001-9006	fluid	_
54-60	9007-9008	)	_
54-61	9009-9010	,	_
54-62	9011-9013	an	_
54-63	9014-9022	approach	_
54-64	9023-9027	that	_
54-65	9028-9031	has	_
54-66	9032-9036	been	_
54-67	9037-9042	shown	_
54-68	9043-9045	to	_
54-69	9046-9056	accurately	_
54-70	9057-9065	describe	_
54-71	9066-9079	physiological	_
54-72	9080-9085	noise	_
54-73	9086-9088	in	_
54-74	9089-9093	grey	_
54-75	9094-9100	matter	_
54-76	9101-9102	.	_

55-1	9103-9110	Finally	_
55-2	9111-9112	,	_
55-3	9113-9114	a	_
55-4	9115-9123	highpass	_
55-5	9124-9130	filter	_
55-6	9131-9135	with	_
55-7	9136-9137	a	_
55-8	9138-9144	cutoff	_
55-9	9145-9147	of	_
55-10	9148-9151	250	_
55-11	9152-9153	s	_
55-12	9154-9155	(	_
55-13	9156-9161	0.004	_
55-14	9162-9164	Hz	_
55-15	9165-9166	)	_
55-16	9167-9170	was	_
55-17	9171-9182	implemented	_
55-18	9183-9185	to	_
55-19	9186-9192	remove	_
55-20	9193-9196	low	_
55-21	9197-9206	frequency	_
55-22	9207-9213	drifts	_
55-23	9214-9219	while	_
55-24	9220-9229	retaining	_
55-25	9230-9234	most	_
55-26	9235-9247	task-related	_
55-27	9248-9259	frequencies	_
55-28	9260-9261	.	_

56-1	9262-9264	At	_
56-2	9265-9268	the	_
56-3	9269-9274	group	_
56-4	9275-9280	level	_
56-5	9281-9282	,	_
56-6	9283-9297	random-effects	_
56-7	9298-9303	group	_
56-8	9304-9312	analyses	_
56-9	9313-9317	were	_
56-10	9318-9327	conducted	_
56-11	9328-9333	using	_
56-12	9334-9336	an	_
56-13	9337-9342	ANOVA	_
56-14	9343-9344	,	_
56-15	9345-9349	with	_
56-16	9350-9359	diagnosis	_
56-17	9360-9362	as	_
56-18	9363-9364	a	_
56-19	9365-9378	between-group	_
56-20	9379-9385	factor	_
56-21	9386-9389	and	_
56-22	9390-9394	task	_
56-23	9395-9404	condition	_
56-24	9405-9407	as	_
56-25	9408-9409	a	_
56-26	9410-9422	within-group	_
56-27	9423-9429	factor	_
56-28	9430-9431	.	_

57-1	9432-9434	If	_
57-2	9435-9438	not	_
57-3	9439-9448	mentioned	_
57-4	9449-9458	otherwise	_
57-5	9459-9460	,	_
57-6	9461-9472	significant	_
57-7	9473-9480	effects	_
57-8	9481-9483	in	_
57-9	9484-9488	fMRI	_
57-10	9489-9497	analyses	_
57-11	9498-9502	were	_
57-12	9503-9510	defined	_
57-13	9511-9513	by	_
57-14	9514-9515	a	_
57-15	9516-9525	corrected	_
57-16	9526-9537	voxel-level	_
57-17	9538-9549	family-wise	_
57-18	9550-9555	error	_
57-19	9556-9557	(	_
57-20	9558-9561	FWE	_
57-21	9562-9563	)	_
57-22	9564-9573	threshold	_
57-23	9574-9576	of	_
57-24	9577-9578	p	_
57-25	9579-9580	<	_
57-26	9581-9585	0.05	_
57-27	9586-9587	.	_

58-1	9588-9595	Dynamic	_
58-2	9596-9602	causal	_
58-3	9603-9611	modeling	_
58-4	9612-9615	VOI	_
58-5	9616-9626	selections	_
58-6	9627-9634	Regions	_
58-7	9635-9639	that	_
58-8	9640-9646	showed	_
58-9	9647-9659	differential	_
58-10	9660-9670	activation	_
58-11	9671-9678	between	_
58-12	9679-9682	the	_
58-13	9683-9691	patients	_
58-14	9692-9695	and	_
58-15	9696-9703	control	_
58-16	9704-9710	groups	_
58-17	9711-9713	in	_
58-18	9714-9717	the	_
58-19	9718-9725	context	_
58-20	9726-9728	of	_
58-21	9729-9731	WM	_
58-22	9732-9733	(	_
58-23	9734-9738	i.e.	_
58-24	9739-9740	,	_
58-25	9741-9742	a	_
58-26	9743-9754	significant	_
58-27	9755-9766	interaction	_
58-28	9767-9774	between	_
58-29	9775-9784	diagnosis	_
58-30	9785-9788	and	_
58-31	9789-9793	task	_
58-32	9794-9795	)	_
58-33	9796-9798	or	_
58-34	9799-9822	activation/deactivation	_
58-35	9823-9825	in	_
58-36	9826-9837	association	_
58-37	9838-9842	with	_
58-38	9843-9846	the	_
58-39	9847-9851	task	_
58-40	9852-9853	(	_
58-41	9854-9858	i.e.	_
58-42	9859-9860	,	_
58-43	9861-9862	a	_
58-44	9863-9874	significant	_
58-45	9875-9879	main	_
58-46	9880-9886	effect	_
58-47	9887-9889	of	_
58-48	9890-9894	task	_
58-49	9895-9896	)	_
58-50	9897-9901	were	_
58-51	9902-9912	considered	_
58-52	9913-9915	as	_
58-53	9916-9923	volumes	_
58-54	9924-9926	of	_
58-55	9927-9935	interest	_
58-56	9936-9937	(	_
58-57	9938-9941	VOI	_
58-58	9942-9943	)	_
58-59	9944-9947	for	_
58-60	9948-9951	use	_
58-61	9952-9954	in	_
58-62	9955-9965	subsequent	_
58-63	9966-9969	DCM	_
58-64	9970-9978	analysis	_
58-65	9979-9980	.	_

59-1	9981-9992	Furthermore	_
59-2	9993-9994	,	_
59-3	9995-9997	in	_
59-4	9998-10003	order	_
59-5	10004-10006	to	_
59-6	10007-10012	focus	_
59-7	10013-10015	on	_
59-8	10016-10019	the	_
59-9	10020-10025	three	_
59-10	10026-10034	networks	_
59-11	10035-10037	of	_
59-12	10038-10046	interest	_
59-13	10047-10048	,	_
59-14	10049-10053	i.e.	_
59-15	10054-10055	,	_
59-16	10056-10062	dorsal	_
59-17	10063-10072	attention	_
59-18	10073-10080	network	_
59-19	10081-10082	(	_
59-20	10083-10086	DAN	_
59-21	10087-10088	)	_
59-22	10089-10090	,	_
59-23	10091-10099	salience	_
59-24	10100-10107	network	_
59-25	10108-10109	(	_
59-26	10110-10112	SN	_
59-27	10113-10114	)	_
59-28	10115-10116	,	_
59-29	10117-10120	and	_
59-30	10121-10133	default-mode	_
59-31	10134-10141	network	_
59-32	10142-10143	(	_
59-33	10144-10147	DMN	_
59-34	10148-10149	)	_
59-35	10150-10151	,	_
59-36	10152-10163	preexisting	_
59-37	10164-10173	templates	_
59-38	10174-10178	were	_
59-39	10179-10183	used	_
59-40	10184-10186	as	_
59-41	10187-10192	masks	_
59-42	10193-10195	to	_
59-43	10196-10204	identify	_
59-44	10205-10209	peak	_
59-45	10210-10216	voxels	_
59-46	10217-10219	in	_
59-47	10220-10223	the	_
59-48	10224-10228	core	_
59-49	10229-10236	regions	_
59-50	10237-10239	in	_
59-51	10240-10244	each	_
59-52	10245-10247	of	_
59-53	10248-10251	the	_
59-54	10252-10257	three	_
59-55	10258-10266	networks	_
59-56	10267-10268	.	_

60-1	10269-10273	This	_
60-2	10274-10283	procedure	_
60-3	10284-10291	defined	_
60-4	10292-10296	four	_
60-5	10297-10302	nodes	_
60-6	10303-10306	for	_
60-7	10307-10310	the	_
60-8	10311-10314	DAN	_
60-9	10315-10316	:	_
60-10	10317-10320	the	_
60-11	10321-10330	bilateral	_
60-12	10331-10338	frontal	_
60-13	10339-10342	eye	_
60-14	10343-10348	field	_
60-15	10349-10350	(	_
60-16	10351-10354	FEF	_
60-17	10355-10356	)	_
60-18	10357-10360	and	_
60-19	10361-10364	the	_
60-20	10365-10374	bilateral	_
60-21	10375-10383	superior	_
60-22	10384-10392	parietal	_
60-23	10393-10399	lobule	_
60-24	10400-10401	(	_
60-25	10402-10405	SPL	_
60-26	10406-10407	)	_
60-27	10408-10409	;	_
60-28	10410-10415	three	_
60-29	10416-10421	nodes	_
60-30	10422-10425	for	_
60-31	10426-10429	the	_
60-32	10430-10432	SN	_
60-33	10433-10434	:	_
60-34	10435-10438	the	_
60-35	10439-10446	SMA/ACC	_
60-36	10447-10448	,	_
60-37	10449-10452	the	_
60-38	10453-10457	left	_
60-39	10458-10466	anterior	_
60-40	10467-10473	insula	_
60-41	10474-10475	(	_
60-42	10476-10478	AI	_
60-43	10479-10480	)	_
60-44	10481-10484	and	_
60-45	10485-10488	the	_
60-46	10489-10494	right	_
60-47	10495-10497	AI	_
60-48	10498-10499	;	_
60-49	10500-10503	two	_
60-50	10504-10509	nodes	_
60-51	10510-10513	for	_
60-52	10514-10517	the	_
60-53	10518-10521	DMN	_
60-54	10522-10523	:	_
60-55	10524-10527	the	_
60-56	10528-10534	medial	_
60-57	10535-10545	prefrontal	_
60-58	10546-10552	cortex	_
60-59	10553-10554	(	_
60-60	10555-10559	MPFC	_
60-61	10560-10561	)	_
60-62	10562-10565	and	_
60-63	10566-10569	the	_
60-64	10570-10579	posterior	_
60-65	10580-10589	cingulate	_
60-66	10590-10596	cortex	_
60-67	10597-10598	(	_
60-68	10599-10602	PCC	_
60-69	10603-10604	)	_
60-70	10605-10606	.	_

61-1	10607-10610	The	_
61-2	10611-10622	group-level	_
61-3	10623-10626	VOI	_
61-4	10627-10636	locations	_
61-5	10637-10640	are	_
61-6	10641-10647	listed	_
61-7	10648-10650	in	_
61-8	10651-10656	Table	_
61-9	10657-10658	2	_
61-10	10659-10660	.	_

62-1	10661-10666	These	_
62-2	10667-10671	were	_
62-3	10672-10680	obtained	_
62-4	10681-10683	by	_
62-5	10684-10696	intersecting	_
62-6	10697-10707	functional	_
62-7	10708-10715	defined	_
62-8	10716-10725	templates	_
62-9	10726-10730	with	_
62-10	10731-10738	regions	_
62-11	10739-10746	showing	_
62-12	10747-10748	a	_
62-13	10749-10760	significant	_
62-14	10761-10772	interaction	_
62-15	10773-10780	between	_
62-16	10781-10790	diagnosis	_
62-17	10791-10794	and	_
62-18	10795-10799	task	_
62-19	10800-10802	or	_
62-20	10803-10807	main	_
62-21	10808-10814	effect	_
62-22	10815-10817	of	_
62-23	10818-10822	task	_
62-24	10823-10825	at	_
62-25	10826-10827	a	_
62-26	10828-10834	lesser	_
62-27	10835-10847	conservative	_
62-28	10848-10857	threshold	_
62-29	10858-10860	of	_
62-30	10861-10874	cluster-level	_
62-31	10875-10878	FWE	_
62-32	10879-10880	p	_
62-33	10881-10882	<	_
62-34	10883-10887	0.05	_
62-35	10888-10889	(	_
62-36	10890-10906	cluster-defining	_
62-37	10907-10916	threshold	_
62-38	10917-10918	p	_
62-39	10919-10920	=	_
62-40	10921-10926	0.001	_
62-41	10927-10928	)	_
62-42	10929-10930	.	_

63-1	10931-10933	We	_
63-2	10934-10938	then	_
63-3	10939-10947	searched	_
63-4	10948-10951	for	_
63-5	10952-10955	the	_
63-6	10956-10961	local	_
63-7	10962-10969	maximum	_
63-8	10970-10976	within	_
63-9	10977-10980	the	_
63-10	10981-10992	group-level	_
63-11	10993-10996	VOI	_
63-12	10997-11000	and	_
63-13	11001-11011	summarized	_
63-14	11012-11015	the	_
63-15	11016-11024	regional	_
63-16	11025-11033	response	_
63-17	11034-11038	with	_
63-18	11039-11042	the	_
63-19	11043-11048	first	_
63-20	11049-11061	eigenvariate	_
63-21	11062-11064	of	_
63-22	11065-11066	(	_
63-23	11067-11085	confound-corrected	_
63-24	11086-11087	)	_
63-25	11088-11094	voxels	_
63-26	11095-11101	within	_
63-27	11102-11103	a	_
63-28	11104-11105	6	_
63-29	11106-11108	mm	_
63-30	11109-11115	radius	_
63-31	11116-11117	.	_

64-1	11118-11121	For	_
64-2	11122-11125	the	_
64-3	11126-11138	participants	_
64-4	11139-11141	in	_
64-5	11142-11147	which	_
64-6	11148-11150	no	_
64-7	11151-11166	supra-threshold	_
64-8	11167-11173	voxels	_
64-9	11174-11178	were	_
64-10	11179-11189	identified	_
64-11	11190-11191	,	_
64-12	11192-11195	the	_
64-13	11196-11201	first	_
64-14	11202-11214	eigenvariate	_
64-15	11215-11218	was	_
64-16	11219-11228	extracted	_
64-17	11229-11233	from	_
64-18	11234-11235	a	_
64-19	11236-11237	6	_
64-20	11238-11240	mm	_
64-21	11241-11247	sphere	_
64-22	11248-11256	centered	_
64-23	11257-11259	at	_
64-24	11260-11263	the	_
64-25	11264-11275	group-level	_
64-26	11276-11283	maximum	_
64-27	11284-11285	.	_

65-1	11286-11296	Individual	_
65-2	11297-11302	level	_
65-3	11303-11306	DCM	_
65-4	11307-11320	specification	_
65-5	11321-11324	and	_
65-6	11325-11334	inversion	_
65-7	11335-11338	DCM	_
65-8	11339-11341	is	_
65-9	11342-11343	a	_
65-10	11344-11353	framework	_
65-11	11354-11357	for	_
65-12	11358-11368	specifying	_
65-13	11369-11370	,	_
65-14	11371-11381	estimating	_
65-15	11382-11385	and	_
65-16	11386-11395	comparing	_
65-17	11396-11406	generative	_
65-18	11407-11413	models	_
65-19	11414-11416	of	_
65-20	11417-11424	imaging	_
65-21	11425-11429	time	_
65-22	11430-11436	series	_
65-23	11437-11438	.	_

66-1	11439-11443	Here	_
66-2	11444-11446	we	_
66-3	11447-11451	used	_
66-4	11452-11455	the	_
66-5	11456-11461	basic	_
66-6	11462-11463	(	_
66-7	11464-11477	deterministic	_
66-8	11478-11479	)	_
66-9	11480-11485	model	_
66-10	11486-11489	for	_
66-11	11490-11494	fMRI	_
66-12	11495-11496	,	_
66-13	11497-11499	in	_
66-14	11500-11505	which	_
66-15	11506-11507	a	_
66-16	11508-11514	vector	_
66-17	11515-11516	z	_
66-18	11517-11518	∈	_
66-19	11519-11521	ℝn	_
66-20	11522-11532	represents	_
66-21	11533-11537	mass	_
66-22	11538-11544	neural	_
66-23	11545-11553	activity	_
66-24	11554-11556	of	_
66-25	11557-11561	each	_
66-26	11562-11567	brain	_
66-27	11568-11574	region	_
66-28	11575-11577	at	_
66-29	11578-11579	a	_
66-30	11580-11585	given	_
66-31	11586-11590	time	_
66-32	11591-11592	.	_

67-1	11593-11596	The	_
67-2	11597-11607	derivative	_
67-3	11608-11610	of	_
67-4	11611-11612	z	_
67-5	11613-11617	with	_
67-6	11618-11625	respect	_
67-7	11626-11628	to	_
67-8	11629-11633	time	_
67-9	11634-11637	can	_
67-10	11638-11640	be	_
67-11	11641-11648	written	_
67-12	11649-11651	as	_
67-13	11652-11653	:	_
67-14	11654-11659	where	_
67-15	11660-11661	u	_
67-16	11662-11664	is	_
67-17	11665-11668	the	_
67-18	11669-11681	experimental	_
67-19	11682-11687	input	_
67-20	11688-11691	and	_
67-21	11692-11694	θn	_
67-22	11695-11698	are	_
67-23	11699-11707	neuronal	_
67-24	11708-11716	coupling	_
67-25	11717-11727	parameters	_
67-26	11728-11732	that	_
67-27	11733-11742	determine	_
67-28	11743-11746	the	_
67-29	11747-11755	strength	_
67-30	11756-11758	of	_
67-31	11759-11770	connections	_
67-32	11771-11777	within	_
67-33	11778-11781	and	_
67-34	11782-11789	between	_
67-35	11790-11795	brain	_
67-36	11796-11803	regions	_
67-37	11804-11805	.	_

68-1	11806-11810	This	_
68-2	11811-11819	function	_
68-3	11820-11822	is	_
68-4	11823-11835	approximated	_
68-5	11836-11841	using	_
68-6	11842-11843	:	_
68-7	11844-11849	where	_
68-8	11850-11859	parameter	_
68-9	11860-11866	matrix	_
68-10	11867-11868	A	_
68-11	11869-11870	∈	_
68-12	11871-11873	ℝn	_
68-13	11874-11875	×	_
68-14	11876-11877	n	_
68-15	11878-11888	represents	_
68-16	11889-11892	the	_
68-17	11893-11905	connectivity	_
68-18	11906-11912	within	_
68-19	11913-11916	and	_
68-20	11917-11924	between	_
68-21	11925-11929	each	_
68-22	11930-11932	of	_
68-23	11933-11936	the	_
68-24	11937-11938	n	_
68-25	11939-11946	regions	_
68-26	11947-11948	(	_
68-27	11949-11954	which	_
68-28	11955-11957	in	_
68-29	11958-11962	this	_
68-30	11963-11968	study	_
68-31	11969-11971	is	_
68-32	11972-11975	the	_
68-33	11976-11983	average	_
68-34	11984-11996	connectivity	_
68-35	11997-11999	of	_
68-36	12000-12006	0-back	_
68-37	12007-12010	and	_
68-38	12011-12017	2-back	_
68-39	12018-12028	conditions	_
68-40	12029-12030	)	_
68-41	12031-12032	,	_
68-42	12033-12034	B	_
68-43	12035-12036	(	_
68-44	12037-12038	j	_
68-45	12039-12040	)	_
68-46	12041-12042	∈	_
68-47	12043-12045	ℝn	_
68-48	12046-12047	×	_
68-49	12048-12049	n	_
68-50	12050-12052	is	_
68-51	12053-12056	the	_
68-52	12057-12067	modulatory	_
68-53	12068-12074	effect	_
68-54	12075-12077	of	_
68-55	12078-12090	experimental	_
68-56	12091-12103	manipulation	_
68-57	12104-12105	j	_
68-58	12106-12108	on	_
68-59	12109-12113	each	_
68-60	12114-12124	connection	_
68-61	12125-12128	and	_
68-62	12129-12130	C	_
68-63	12131-12132	∈	_
68-64	12133-12135	ℝn	_
68-65	12136-12137	×	_
68-66	12138-12139	J	_
68-67	12140-12142	is	_
68-68	12143-12146	the	_
68-69	12147-12153	direct	_
68-70	12154-12161	driving	_
68-71	12162-12171	influence	_
68-72	12172-12174	of	_
68-73	12175-12179	each	_
68-74	12180-12182	of	_
68-75	12183-12186	the	_
68-76	12187-12188	J	_
68-77	12189-12201	experimental	_
68-78	12202-12212	conditions	_
68-79	12213-12215	on	_
68-80	12216-12220	each	_
68-81	12221-12227	region	_
68-82	12228-12229	.	_

69-1	12230-12233	The	_
69-2	12234-12243	predicted	_
69-3	12244-12252	neuronal	_
69-4	12253-12261	activity	_
69-5	12262-12268	enters	_
69-6	12269-12270	a	_
69-7	12271-12283	haemodynamic	_
69-8	12284-12289	model	_
69-9	12290-12294	that	_
69-10	12295-12307	incorporates	_
69-11	12308-12309	a	_
69-12	12310-12315	model	_
69-13	12316-12318	of	_
69-14	12319-12332	neurovascular	_
69-15	12333-12341	coupling	_
69-16	12342-12345	and	_
69-17	12346-12349	the	_
69-18	12350-12360	subsequent	_
69-19	12361-12365	BOLD	_
69-20	12366-12374	response	_
69-21	12375-12376	.	_

70-1	12377-12381	This	_
70-2	12382-12390	provides	_
70-3	12391-12394	the	_
70-4	12395-12404	predicted	_
70-5	12405-12409	fMRI	_
70-6	12410-12414	time	_
70-7	12415-12421	series	_
70-8	12422-12426	that	_
70-9	12427-12430	one	_
70-10	12431-12436	would	_
70-11	12437-12443	expect	_
70-12	12444-12446	to	_
70-13	12447-12454	measure	_
70-14	12455-12456	,	_
70-15	12457-12462	given	_
70-16	12463-12466	the	_
70-17	12467-12479	connectivity	_
70-18	12480-12490	parameters	_
70-19	12491-12493	θn	_
70-20	12494-12495	=	_
70-21	12496-12497	(	_
70-22	12498-12499	A	_
70-23	12500-12501	,	_
70-24	12502-12503	B	_
70-25	12504-12505	,	_
70-26	12506-12507	C	_
70-27	12508-12509	)	_
70-28	12510-12511	.	_

71-1	12512-12514	We	_
71-2	12515-12524	specified	_
71-3	12525-12526	a	_
71-4	12527-12530	DCM	_
71-5	12531-12534	for	_
71-6	12535-12539	each	_
71-7	12540-12551	participant	_
71-8	12552-12553	.	_

72-1	12554-12559	Model	_
72-2	12560-12573	specification	_
72-3	12574-12582	involved	_
72-4	12583-12590	setting	_
72-5	12591-12596	prior	_
72-6	12597-12606	variances	_
72-7	12607-12609	on	_
72-8	12610-12613	the	_
72-9	12614-12624	parameters	_
72-10	12625-12627	in	_
72-11	12628-12636	matrices	_
72-12	12637-12638	A	_
72-13	12639-12640	,	_
72-14	12641-12642	B	_
72-15	12643-12646	and	_
72-16	12647-12648	C	_
72-17	12649-12650	,	_
72-18	12651-12656	where	_
72-19	12657-12658	a	_
72-20	12659-12664	prior	_
72-21	12665-12673	variance	_
72-22	12674-12676	of	_
72-23	12677-12681	zero	_
72-24	12682-12683	‘	_
72-25	12684-12692	switches	_
72-26	12693-12696	off	_
72-27	12697-12698	’	_
72-28	12699-12700	a	_
72-29	12701-12711	connection	_
72-30	12712-12715	and	_
72-31	12716-12717	a	_
72-32	12718-12726	non-zero	_
72-33	12727-12732	prior	_
72-34	12733-12741	variance	_
72-35	12742-12743	‘	_
72-36	12744-12752	switches	_
72-37	12753-12755	on	_
72-38	12756-12757	’	_
72-39	12758-12759	a	_
72-40	12760-12770	connection	_
72-41	12771-12772	–	_
72-42	12773-12775	so	_
72-43	12776-12780	that	_
72-44	12781-12783	it	_
72-45	12784-12787	can	_
72-46	12788-12790	be	_
72-47	12791-12799	informed	_
72-48	12800-12802	by	_
72-49	12803-12807	data	_
72-50	12808-12809	.	_

73-1	12810-12814	Here	_
73-2	12815-12816	,	_
73-3	12817-12822	there	_
73-4	12823-12827	were	_
73-5	12828-12831	two	_
73-6	12832-12844	experimental	_
73-7	12845-12851	inputs	_
73-8	12852-12853	(	_
73-9	12854-12855	J	_
73-10	12856-12857	=	_
73-11	12858-12859	2	_
73-12	12860-12861	)	_
73-13	12862-12863	:	_
73-14	12864-12867	the	_
73-15	12868-12872	main	_
73-16	12873-12879	effect	_
73-17	12880-12882	of	_
73-18	12883-12887	task	_
73-19	12888-12889	(	_
73-20	12890-12893	all	_
73-21	12894-12900	0-back	_
73-22	12901-12904	and	_
73-23	12905-12911	2-back	_
73-24	12912-12918	events	_
73-25	12919-12920	)	_
73-26	12921-12924	and	_
73-27	12925-12932	working	_
73-28	12933-12939	memory	_
73-29	12940-12944	load	_
73-30	12945-12946	(	_
73-31	12947-12958	contrasting	_
73-32	12959-12965	0-back	_
73-33	12966-12970	with	_
73-34	12971-12977	2-back	_
73-35	12978-12979	)	_
73-36	12980-12981	.	_

74-1	12982-12986	Task	_
74-2	12987-12994	entered	_
74-3	12995-12998	the	_
74-4	12999-13004	model	_
74-5	13005-13007	as	_
74-6	13008-13009	a	_
74-7	13010-13017	driving	_
74-8	13018-13023	input	_
74-9	13024-13025	(	_
74-10	13026-13028	by	_
74-11	13029-13036	setting	_
74-12	13037-13040	the	_
74-13	13041-13052	appropriate	_
74-14	13053-13059	priors	_
74-15	13060-13062	in	_
74-16	13063-13069	matrix	_
74-17	13070-13071	C	_
74-18	13072-13073	)	_
74-19	13074-13075	.	_

75-1	13076-13083	Working	_
75-2	13084-13090	memory	_
75-3	13091-13095	load	_
75-4	13096-13103	entered	_
75-5	13104-13107	the	_
75-6	13108-13113	model	_
75-7	13114-13116	as	_
75-8	13117-13118	a	_
75-9	13119-13129	modulatory	_
75-10	13130-13135	input	_
75-11	13136-13138	on	_
75-12	13139-13143	each	_
75-13	13144-13150	region	_
75-14	13151-13153	's	_
75-15	13154-13169	self-connection	_
75-16	13170-13171	(	_
75-17	13172-13176	i.e.	_
75-18	13177-13178	,	_
75-19	13179-13188	intrinsic	_
75-20	13189-13199	connection	_
75-21	13200-13201	)	_
75-22	13202-13204	by	_
75-23	13205-13212	setting	_
75-24	13213-13216	the	_
75-25	13217-13228	appropriate	_
75-26	13229-13235	priors	_
75-27	13236-13238	on	_
75-28	13239-13245	matrix	_
75-29	13246-13247	B	_
75-30	13248-13249	.	_

76-1	13250-13253	The	_
76-2	13254-13270	self-connections	_
76-3	13271-13279	regulate	_
76-4	13280-13281	a	_
76-5	13282-13288	region	_
76-6	13289-13291	's	_
76-7	13292-13300	response	_
76-8	13301-13303	to	_
76-9	13304-13307	its	_
76-10	13308-13314	inputs	_
76-11	13315-13316	;	_
76-12	13317-13321	i.e.	_
76-13	13322-13323	,	_
76-14	13324-13328	they	_
76-15	13329-13336	provide	_
76-16	13337-13341	gain	_
76-17	13342-13349	control	_
76-18	13350-13352	in	_
76-19	13353-13356	the	_
76-20	13357-13362	model	_
76-21	13363-13364	,	_
76-22	13365-13369	akin	_
76-23	13370-13372	to	_
76-24	13373-13383	inhibitory	_
76-25	13384-13397	inter-neurons	_
76-26	13398-13399	–	_
76-27	13400-13403	and	_
76-28	13404-13414	consequent	_
76-29	13415-13436	excitation-inhibition	_
76-30	13437-13444	balance	_
76-31	13445-13446	–	_
76-32	13447-13449	in	_
76-33	13450-13453	the	_
76-34	13454-13459	brain	_
76-35	13460-13461	.	_

77-1	13462-13466	Thus	_
77-2	13467-13468	,	_
77-3	13469-13471	we	_
77-4	13472-13479	modeled	_
77-5	13480-13487	working	_
77-6	13488-13494	memory	_
77-7	13495-13499	load	_
77-8	13500-13502	as	_
77-9	13503-13512	modifying	_
77-10	13513-13516	the	_
77-11	13517-13528	sensitivity	_
77-12	13529-13531	of	_
77-13	13532-13536	each	_
77-14	13537-13543	region	_
77-15	13544-13546	to	_
77-16	13547-13552	input	_
77-17	13553-13557	from	_
77-18	13558-13561	the	_
77-19	13562-13566	rest	_
77-20	13567-13569	of	_
77-21	13570-13573	the	_
77-22	13574-13581	network	_
77-23	13582-13583	.	_

78-1	13584-13588	Each	_
78-2	13589-13596	subject	_
78-3	13597-13599	's	_
78-4	13600-13605	model	_
78-5	13606-13609	was	_
78-6	13610-13618	inverted	_
78-7	13619-13620	,	_
78-8	13621-13630	providing	_
78-9	13631-13640	estimates	_
78-10	13641-13643	of	_
78-11	13644-13647	the	_
78-12	13648-13658	connection	_
78-13	13659-13667	strength	_
78-14	13668-13678	parameters	_
78-15	13679-13680	θ	_
78-16	13681-13682	(	_
78-17	13683-13684	n	_
78-18	13685-13686	)	_
78-19	13687-13692	which	_
78-20	13693-13697	best	_
78-21	13698-13707	explained	_
78-22	13708-13711	the	_
78-23	13712-13720	observed	_
78-24	13721-13725	data	_
78-25	13726-13727	.	_

79-1	13728-13731	The	_
79-2	13732-13741	resulting	_
79-3	13742-13751	posterior	_
79-4	13752-13761	densities	_
79-5	13762-13766	were	_
79-6	13767-13775	normally	_
79-7	13776-13787	distributed	_
79-8	13788-13789	,	_
79-9	13790-13794	with	_
79-10	13795-13803	expected	_
79-11	13804-13810	values	_
79-12	13811-13814	and	_
79-13	13815-13825	covariance	_
79-14	13826-13827	(	_
79-15	13828-13839	uncertainty	_
79-16	13840-13841	)	_
79-17	13842-13843	.	_

80-1	13844-13849	Model	_
80-2	13850-13860	estimation	_
80-3	13861-13873	additionally	_
80-4	13874-13882	provided	_
80-5	13883-13886	the	_
80-6	13887-13891	free	_
80-7	13892-13898	energy	_
80-8	13899-13912	approximation	_
80-9	13913-13915	to	_
80-10	13916-13919	log	_
80-11	13920-13925	model	_
80-12	13926-13934	evidence	_
80-13	13935-13936	F	_
80-14	13937-13938	,	_
80-15	13939-13944	which	_
80-16	13945-13951	scores	_
80-17	13952-13955	the	_
80-18	13956-13963	quality	_
80-19	13964-13966	of	_
80-20	13967-13971	each	_
80-21	13972-13977	model	_
80-22	13978-13980	in	_
80-23	13981-13986	terms	_
80-24	13987-13989	of	_
80-25	13990-13998	accuracy	_
80-26	13999-14002	and	_
80-27	14003-14013	complexity	_
80-28	14014-14015	:	_
80-29	14016-14021	where	_
80-30	14022-14023	y	_
80-31	14024-14026	is	_
80-32	14027-14030	the	_
80-33	14031-14035	data	_
80-34	14036-14039	and	_
80-35	14040-14041	m	_
80-36	14042-14044	is	_
80-37	14045-14048	the	_
80-38	14049-14054	model	_
80-39	14055-14056	.	_

81-1	14057-14060	One	_
81-2	14061-14065	uses	_
81-3	14066-14069	the	_
81-4	14070-14074	free	_
81-5	14075-14081	energy	_
81-6	14082-14083	F	_
81-7	14084-14086	to	_
81-8	14087-14094	compare	_
81-9	14095-14104	competing	_
81-10	14105-14111	models	_
81-11	14112-14113	,	_
81-12	14114-14116	in	_
81-13	14117-14122	order	_
81-14	14123-14125	to	_
81-15	14126-14130	find	_
81-16	14131-14134	the	_
81-17	14135-14140	least	_
81-18	14141-14148	complex	_
81-19	14149-14154	model	_
81-20	14155-14157	of	_
81-21	14158-14161	the	_
81-22	14162-14166	data	_
81-23	14167-14171	that	_
81-24	14172-14182	accurately	_
81-25	14183-14191	explains	_
81-26	14192-14195	the	_
81-27	14196-14200	most	_
81-28	14201-14209	variance	_
81-29	14210-14211	.	_

82-1	14212-14221	Empirical	_
82-2	14222-14227	Bayes	_
82-3	14228-14231	for	_
82-4	14232-14237	group	_
82-5	14238-14241	DCM	_
82-6	14242-14248	Having	_
82-7	14249-14255	fitted	_
82-8	14256-14260	each	_
82-9	14261-14268	subject	_
82-10	14269-14271	's	_
82-11	14272-14275	DCM	_
82-12	14276-14278	to	_
82-13	14279-14284	their	_
82-14	14285-14289	data	_
82-15	14290-14291	,	_
82-16	14292-14294	we	_
82-17	14295-14299	next	_
82-18	14300-14309	performed	_
82-19	14310-14311	a	_
82-20	14312-14318	second	_
82-21	14319-14324	level	_
82-22	14325-14333	analysis	_
82-23	14334-14336	to	_
82-24	14337-14345	estimate	_
82-25	14346-14349	the	_
82-26	14350-14355	group	_
82-27	14356-14360	mean	_
82-28	14361-14364	and	_
82-29	14365-14368	the	_
82-30	14369-14375	effect	_
82-31	14376-14378	of	_
82-32	14379-14388	diagnosis	_
82-33	14389-14392	for	_
82-34	14393-14397	each	_
82-35	14398-14408	connection	_
82-36	14409-14410	.	_

83-1	14411-14415	This	_
83-2	14416-14420	used	_
83-3	14421-14429	recently	_
83-4	14430-14439	developed	_
83-5	14440-14448	routines	_
83-6	14449-14452	for	_
83-7	14453-14461	modeling	_
83-8	14462-14474	connectivity	_
83-9	14475-14477	at	_
83-10	14478-14481	the	_
83-11	14482-14487	group	_
83-12	14488-14493	level	_
83-13	14494-14495	(	_
83-14	14496-14506	Parametric	_
83-15	14507-14516	Empirical	_
83-16	14517-14522	Bayes	_
83-17	14523-14524	)	_
83-18	14525-14527	in	_
83-19	14528-14531	the	_
83-20	14532-14539	context	_
83-21	14540-14542	of	_
83-22	14543-14546	DCM	_
83-23	14547-14548	.	_

84-1	14549-14559	Parametric	_
84-2	14560-14569	Empirical	_
84-3	14570-14575	Bayes	_
84-4	14576-14577	(	_
84-5	14578-14581	PEB	_
84-6	14582-14583	)	_
84-7	14584-14586	is	_
84-8	14587-14588	a	_
84-9	14589-14604	between-subject	_
84-10	14605-14617	hierarchical	_
84-11	14618-14620	or	_
84-12	14621-14630	empirical	_
84-13	14631-14639	Bayesian	_
84-14	14640-14645	model	_
84-15	14646-14650	over	_
84-16	14651-14661	parameters	_
84-17	14662-14666	that	_
84-18	14667-14673	models	_
84-19	14674-14677	how	_
84-20	14678-14688	individual	_
84-21	14689-14690	(	_
84-22	14691-14705	within-subject	_
84-23	14706-14707	)	_
84-24	14708-14719	connections	_
84-25	14720-14726	relate	_
84-26	14727-14729	to	_
84-27	14730-14735	group	_
84-28	14736-14738	or	_
84-29	14739-14748	condition	_
84-30	14749-14754	means	_
84-31	14755-14756	.	_

85-1	14757-14761	This	_
85-2	14762-14774	hierarchical	_
85-3	14775-14783	approach	_
85-4	14784-14790	treats	_
85-5	14791-14795	each	_
85-6	14796-14806	connection	_
85-7	14807-14809	as	_
85-8	14810-14811	a	_
85-9	14812-14818	random	_
85-10	14819-14820	(	_
85-11	14821-14836	between-subject	_
85-12	14837-14838	)	_
85-13	14839-14845	effect	_
85-14	14846-14847	,	_
85-15	14848-14853	which	_
85-16	14854-14856	is	_
85-17	14857-14864	modeled	_
85-18	14865-14867	by	_
85-19	14868-14874	adding	_
85-20	14875-14876	a	_
85-21	14877-14883	random	_
85-22	14884-14892	Gaussian	_
85-23	14893-14902	variation	_
85-24	14903-14905	to	_
85-25	14906-14922	subject-specific	_
85-26	14923-14934	predictions	_
85-27	14935-14936	,	_
85-28	14937-14942	based	_
85-29	14943-14947	upon	_
85-30	14948-14951	the	_
85-31	14952-14957	group	_
85-32	14958-14962	mean	_
85-33	14963-14975	connectivity	_
85-34	14976-14978	as	_
85-35	14979-14983	well	_
85-36	14984-14986	as	_
85-37	14987-15002	between-subject	_
85-38	15003-15010	effects	_
85-39	15011-15015	such	_
85-40	15016-15018	as	_
85-41	15019-15028	diagnosis	_
85-42	15029-15031	or	_
85-43	15032-15035	age	_
85-44	15036-15037	.	_

86-1	15038-15042	This	_
86-2	15043-15053	parametric	_
86-3	15054-15060	random	_
86-4	15061-15068	effects	_
86-5	15069-15077	modeling	_
86-6	15078-15080	is	_
86-7	15081-15090	important	_
86-8	15091-15098	because	_
86-9	15099-15100	,	_
86-10	15101-15107	unlike	_
86-11	15108-15109	a	_
86-12	15110-15119	classical	_
86-13	15120-15124	test	_
86-14	15125-15126	(	_
86-15	15127-15130	e.g	_
86-16	15131-15132	.	_

87-1	15133-15139	t-test	_
87-2	15140-15141	)	_
87-3	15142-15143	,	_
87-4	15144-15146	it	_
87-5	15147-15151	uses	_
87-6	15152-15155	the	_
87-7	15156-15160	full	_
87-8	15161-15170	posterior	_
87-9	15171-15178	density	_
87-10	15179-15183	over	_
87-11	15184-15187	the	_
87-12	15188-15198	parameters	_
87-13	15199-15203	from	_
87-14	15204-15208	each	_
87-15	15209-15216	subject	_
87-16	15217-15219	's	_
87-17	15220-15223	DCM	_
87-18	15224-15225	–	_
87-19	15226-15230	both	_
87-20	15231-15234	the	_
87-21	15235-15243	expected	_
87-22	15244-15252	strength	_
87-23	15253-15255	of	_
87-24	15256-15260	each	_
87-25	15261-15271	connection	_
87-26	15272-15275	and	_
87-27	15276-15279	the	_
87-28	15280-15290	associated	_
87-29	15291-15302	uncertainty	_
87-30	15303-15304	(	_
87-31	15305-15308	i.e	_
87-32	15309-15310	.	_

88-1	15311-15320	posterior	_
88-2	15321-15331	covariance	_
88-3	15332-15333	)	_
88-4	15334-15335	–	_
88-5	15336-15338	to	_
88-6	15339-15345	inform	_
88-7	15346-15349	the	_
88-8	15350-15361	group-level	_
88-9	15362-15368	result	_
88-10	15369-15370	(	_
88-11	15371-15375	i.e.	_
88-12	15376-15377	,	_
88-13	15378-15383	group	_
88-14	15384-15395	differences	_
88-15	15396-15397	)	_
88-16	15398-15399	.	_

89-1	15400-15401	A	_
89-2	15402-15405	PEB	_
89-3	15406-15411	model	_
89-4	15412-15415	has	_
89-5	15416-15419	the	_
89-6	15420-15429	following	_
89-7	15430-15434	form	_
89-8	15435-15436	:	_
89-9	15437-15445	Starting	_
89-10	15446-15450	with	_
89-11	15451-15454	the	_
89-12	15455-15459	last	_
89-13	15460-15464	line	_
89-14	15465-15466	,	_
89-15	15467-15470	the	_
89-16	15471-15479	observed	_
89-17	15480-15484	fMRI	_
89-18	15485-15489	data	_
89-19	15490-15492	yi	_
89-20	15493-15496	for	_
89-21	15497-15504	subject	_
89-22	15505-15506	i	_
89-23	15507-15509	is	_
89-24	15510-15519	generated	_
89-25	15520-15522	by	_
89-26	15523-15531	function	_
89-27	15532-15534	Γi	_
89-28	15535-15536	(	_
89-29	15537-15538	1	_
89-30	15539-15540	)	_
89-31	15541-15542	,	_
89-32	15543-15548	which	_
89-33	15549-15553	here	_
89-34	15554-15556	is	_
89-35	15557-15560	the	_
89-36	15561-15568	subject	_
89-37	15569-15571	's	_
89-38	15572-15575	DCM	_
89-39	15576-15577	,	_
89-40	15578-15582	with	_
89-41	15583-15593	parameters	_
89-42	15594-15595	θ	_
89-43	15596-15597	(	_
89-44	15598-15599	1	_
89-45	15600-15601	)	_
89-46	15602-15605	and	_
89-47	15606-15617	observation	_
89-48	15618-15623	noise	_
89-49	15624-15626	ϵi	_
89-50	15627-15628	(	_
89-51	15629-15630	1	_
89-52	15631-15632	)	_
89-53	15633-15634	.	_

90-1	15635-15638	The	_
90-2	15639-15651	contribution	_
90-3	15652-15654	of	_
90-4	15655-15658	the	_
90-5	15659-15662	PEB	_
90-6	15663-15672	framework	_
90-7	15673-15675	is	_
90-8	15676-15680	that	_
90-9	15681-15684	the	_
90-10	15685-15688	DCM	_
90-11	15689-15699	parameters	_
90-12	15700-15701	θ	_
90-13	15702-15703	(	_
90-14	15704-15705	1	_
90-15	15706-15707	)	_
90-16	15708-15711	are	_
90-17	15712-15722	themselves	_
90-18	15723-15734	represented	_
90-19	15735-15737	by	_
90-20	15738-15739	a	_
90-21	15740-15745	group	_
90-22	15746-15748	or	_
90-23	15749-15761	second-level	_
90-24	15762-15767	model	_
90-25	15768-15769	,	_
90-26	15770-15777	written	_
90-27	15778-15780	on	_
90-28	15781-15784	the	_
90-29	15785-15791	second	_
90-30	15792-15796	line	_
90-31	15797-15799	of	_
90-32	15800-15803	the	_
90-33	15804-15812	equation	_
90-34	15813-15814	.	_

91-1	15815-15818	The	_
91-2	15819-15825	second	_
91-3	15826-15831	level	_
91-4	15832-15840	function	_
91-5	15841-15842	Γ	_
91-6	15843-15844	(	_
91-7	15845-15846	2	_
91-8	15847-15848	)	_
91-9	15849-15852	has	_
91-10	15853-15863	parameters	_
91-11	15864-15865	(	_
91-12	15866-15870	e.g.	_
91-13	15871-15872	,	_
91-14	15873-15880	average	_
91-15	15881-15891	connection	_
91-16	15892-15901	strengths	_
91-17	15902-15903	)	_
91-18	15904-15905	θ	_
91-19	15906-15907	(	_
91-20	15908-15909	2	_
91-21	15910-15911	)	_
91-22	15912-15913	,	_
91-23	15914-15918	plus	_
91-24	15919-15934	between-subject	_
91-25	15935-15946	variability	_
91-26	15947-15948	ϵ	_
91-27	15949-15950	(	_
91-28	15951-15952	2	_
91-29	15953-15954	)	_
91-30	15955-15956	.	_

92-1	15957-15964	Finally	_
92-2	15965-15966	,	_
92-3	15967-15972	these	_
92-4	15973-15979	second	_
92-5	15980-15985	level	_
92-6	15986-15996	parameters	_
92-7	15997-16001	have	_
92-8	16002-16008	priors	_
92-9	16009-16010	,	_
92-10	16011-16015	with	_
92-11	16016-16020	mean	_
92-12	16021-16022	η	_
92-13	16023-16024	,	_
92-14	16025-16027	as	_
92-15	16028-16037	specified	_
92-16	16038-16040	on	_
92-17	16041-16044	the	_
92-18	16045-16050	first	_
92-19	16051-16055	line	_
92-20	16056-16058	of	_
92-21	16059-16062	the	_
92-22	16063-16071	equation	_
92-23	16072-16073	.	_

93-1	16074-16076	In	_
93-2	16077-16081	this	_
93-3	16082-16087	study	_
93-4	16088-16089	,	_
93-5	16090-16093	the	_
93-6	16094-16099	first	_
93-7	16100-16101	(	_
93-8	16102-16116	within-subject	_
93-9	16117-16118	)	_
93-10	16119-16124	level	_
93-11	16125-16127	of	_
93-12	16128-16131	the	_
93-13	16132-16137	model	_
93-14	16138-16140	is	_
93-15	16141-16144	the	_
93-16	16145-16153	standard	_
93-17	16154-16167	deterministic	_
93-18	16168-16171	DCM	_
93-19	16172-16175	for	_
93-20	16176-16180	fMRI	_
93-21	16181-16182	,	_
93-22	16183-16188	where	_
93-23	16189-16192	the	_
93-24	16193-16203	parameters	_
93-25	16204-16214	correspond	_
93-26	16215-16217	to	_
93-27	16218-16227	effective	_
93-28	16228-16240	connectivity	_
93-29	16241-16242	(	_
93-30	16243-16249	please	_
93-31	16250-16253	see	_
93-32	16254-16259	above	_
93-33	16260-16261	)	_
93-34	16262-16263	.	_

94-1	16264-16267	The	_
94-2	16268-16274	second	_
94-3	16275-16276	(	_
94-4	16277-16292	between-subject	_
94-5	16293-16294	)	_
94-6	16295-16300	level	_
94-7	16301-16306	model	_
94-8	16307-16308	Γ	_
94-9	16309-16310	(	_
94-10	16311-16312	2	_
94-11	16313-16314	)	_
94-12	16315-16317	is	_
94-13	16318-16324	simply	_
94-14	16325-16326	a	_
94-15	16327-16330	GLM	_
94-16	16331-16335	with	_
94-17	16336-16339	the	_
94-18	16340-16344	form	_
94-19	16345-16346	:	_
94-20	16347-16352	where	_
94-21	16353-16354	X	_
94-22	16355-16356	∈	_
94-23	16357-16359	ℝS	_
94-24	16360-16361	×	_
94-25	16362-16363	C	_
94-26	16364-16366	is	_
94-27	16367-16370	the	_
94-28	16371-16377	design	_
94-29	16378-16384	matrix	_
94-30	16385-16386	(	_
94-31	16387-16388	S	_
94-32	16389-16391	is	_
94-33	16392-16395	the	_
94-34	16396-16402	number	_
94-35	16403-16405	of	_
94-36	16406-16414	subjects	_
94-37	16415-16416	,	_
94-38	16417-16418	C	_
94-39	16419-16421	is	_
94-40	16422-16425	the	_
94-41	16426-16432	number	_
94-42	16433-16435	of	_
94-43	16436-16446	covariates	_
94-44	16447-16448	)	_
94-45	16449-16450	,	_
94-46	16451-16453	IP	_
94-47	16454-16456	is	_
94-48	16457-16460	the	_
94-49	16461-16469	identity	_
94-50	16470-16476	matrix	_
94-51	16477-16479	of	_
94-52	16480-16489	dimension	_
94-53	16490-16491	P	_
94-54	16492-16493	(	_
94-55	16494-16499	where	_
94-56	16500-16501	P	_
94-57	16502-16504	is	_
94-58	16505-16508	the	_
94-59	16509-16515	number	_
94-60	16516-16518	of	_
94-61	16519-16529	connection	_
94-62	16530-16540	parameters	_
94-63	16541-16543	in	_
94-64	16544-16547	the	_
94-65	16548-16551	DCM	_
94-66	16552-16553	)	_
94-67	16554-16557	and	_
94-68	16558-16561	the	_
94-69	16562-16570	operator	_
94-70	16571-16572	⊗	_
94-71	16573-16575	is	_
94-72	16576-16579	the	_
94-73	16580-16589	Kronecker	_
94-74	16590-16597	product	_
94-75	16598-16602	that	_
94-76	16603-16613	duplicates	_
94-77	16614-16618	each	_
94-78	16619-16626	element	_
94-79	16627-16629	of	_
94-80	16630-16633	the	_
94-81	16634-16640	design	_
94-82	16641-16647	matrix	_
94-83	16648-16651	for	_
94-84	16652-16656	each	_
94-85	16657-16660	DCM	_
94-86	16661-16670	parameter	_
94-87	16671-16672	.	_

95-1	16673-16675	In	_
95-2	16676-16681	other	_
95-3	16682-16687	words	_
95-4	16688-16689	,	_
95-5	16690-16694	this	_
95-6	16695-16700	model	_
95-7	16701-16707	allows	_
95-8	16708-16711	for	_
95-9	16712-16717	every	_
95-10	16718-16725	between	_
95-11	16726-16740	subject-effect	_
95-12	16741-16743	to	_
95-13	16744-16746	be	_
95-14	16747-16756	expressed	_
95-15	16757-16759	at	_
95-16	16760-16765	every	_
95-17	16766-16780	within-subject	_
95-18	16781-16787	effect	_
95-19	16788-16789	.	_

96-1	16790-16793	The	_
96-2	16794-16804	parameters	_
96-3	16805-16807	of	_
96-4	16808-16811	the	_
96-5	16812-16815	GLM	_
96-6	16816-16819	are	_
96-7	16820-16821	β	_
96-8	16822-16823	⊂	_
96-9	16824-16825	θ	_
96-10	16826-16827	(	_
96-11	16828-16829	2	_
96-12	16830-16831	)	_
96-13	16832-16833	.	_

97-1	16834-16838	Thus	_
97-2	16839-16840	,	_
97-3	16841-16843	we	_
97-4	16844-16847	had	_
97-5	16848-16851	one	_
97-6	16852-16853	β	_
97-7	16854-16863	parameter	_
97-8	16864-16876	representing	_
97-9	16877-16880	the	_
97-10	16881-16887	effect	_
97-11	16888-16890	of	_
97-12	16891-16895	each	_
97-13	16896-16897	(	_
97-14	16898-16913	between-subject	_
97-15	16914-16915	)	_
97-16	16916-16925	covariate	_
97-17	16926-16928	on	_
97-18	16929-16933	each	_
97-19	16934-16937	DCM	_
97-20	16938-16948	connection	_
97-21	16949-16950	.	_

98-1	16951-16954	The	_
98-2	16955-16961	priors	_
98-3	16962-16964	on	_
98-4	16965-16970	these	_
98-5	16971-16977	second	_
98-6	16978-16983	level	_
98-7	16984-16994	parameters	_
98-8	16995-16999	were	_
98-9	17000-17003	set	_
98-10	17004-17006	to	_
98-11	17007-17012	match	_
98-12	17013-17016	the	_
98-13	17017-17023	priors	_
98-14	17024-17026	of	_
98-15	17027-17030	the	_
98-16	17031-17036	first	_
98-17	17037-17042	level	_
98-18	17043-17053	parameters	_
98-19	17054-17055	.	_

99-1	17056-17058	In	_
99-2	17059-17064	order	_
99-3	17065-17067	to	_
99-4	17068-17076	identify	_
99-5	17077-17088	differences	_
99-6	17089-17096	between	_
99-7	17097-17105	patients	_
99-8	17106-17110	with	_
99-9	17111-17124	schizophrenia	_
99-10	17125-17128	and	_
99-11	17129-17135	normal	_
99-12	17136-17144	controls	_
99-13	17145-17146	,	_
99-14	17147-17149	we	_
99-15	17150-17158	included	_
99-16	17159-17162	two	_
99-17	17163-17173	covariates	_
99-18	17174-17176	of	_
99-19	17177-17185	interest	_
99-20	17186-17188	in	_
99-21	17189-17192	the	_
99-22	17193-17199	design	_
99-23	17200-17206	matrix	_
99-24	17207-17208	X	_
99-25	17209-17210	:	_
99-26	17211-17214	the	_
99-27	17215-17220	group	_
99-28	17221-17225	mean	_
99-29	17226-17229	and	_
99-30	17230-17239	diagnosis	_
99-31	17240-17241	.	_

100-1	17242-17244	We	_
100-2	17245-17249	also	_
100-3	17250-17258	included	_
100-4	17259-17262	the	_
100-5	17263-17270	working	_
100-6	17271-17277	memory	_
100-7	17278-17289	performance	_
100-8	17290-17297	indexed	_
100-9	17298-17300	by	_
100-10	17301-17304	the	_
100-11	17305-17310	ratio	_
100-12	17311-17318	between	_
100-13	17319-17322	d′2	_
100-14	17323-17328	score	_
100-15	17329-17332	and	_
100-16	17333-17336	d′0	_
100-17	17337-17342	score	_
100-18	17343-17346	and	_
100-19	17347-17350	the	_
100-20	17351-17362	interaction	_
100-21	17363-17370	between	_
100-22	17371-17380	diagnosis	_
100-23	17381-17384	and	_
100-24	17385-17396	performance	_
100-25	17397-17399	as	_
100-26	17400-17408	nuisance	_
100-27	17409-17419	covariates	_
100-28	17420-17421	,	_
100-29	17422-17424	in	_
100-30	17425-17430	order	_
100-31	17431-17433	to	_
100-32	17434-17441	exclude	_
100-33	17442-17445	the	_
100-34	17446-17455	potential	_
100-35	17456-17465	influence	_
100-36	17466-17468	of	_
100-37	17469-17480	performance	_
100-38	17481-17491	components	_
100-39	17492-17494	on	_
100-40	17495-17498	the	_
100-41	17499-17504	group	_
100-42	17505-17509	mean	_
100-43	17510-17513	and	_
100-44	17514-17523	diagnosis	_
100-45	17524-17530	effect	_
100-46	17531-17532	.	_

101-1	17533-17536	The	_
101-2	17537-17552	between-subject	_
101-3	17553-17564	variability	_
101-4	17565-17566	ϵ	_
101-5	17567-17568	(	_
101-6	17569-17570	2	_
101-7	17571-17572	)	_
101-8	17573-17577	with	_
101-9	17578-17587	precision	_
101-10	17588-17589	Π	_
101-11	17590-17591	(	_
101-12	17592-17593	2	_
101-13	17594-17595	)	_
101-14	17596-17599	was	_
101-15	17600-17613	parameterized	_
101-16	17614-17619	using	_
101-17	17620-17621	a	_
101-18	17622-17628	single	_
101-19	17629-17638	precision	_
101-20	17639-17648	parameter	_
101-21	17649-17650	γ	_
101-22	17651-17652	:	_
101-23	17653-17658	where	_
101-24	17659-17661	Q0	_
101-25	17662-17664	is	_
101-26	17665-17668	the	_
101-27	17669-17674	lower	_
101-28	17675-17680	bound	_
101-29	17681-17683	on	_
101-30	17684-17693	precision	_
101-31	17694-17695	,	_
101-32	17696-17701	which	_
101-33	17702-17707	takes	_
101-34	17708-17710	on	_
101-35	17711-17712	a	_
101-36	17713-17718	small	_
101-37	17719-17727	positive	_
101-38	17728-17733	value	_
101-39	17734-17735	,	_
101-40	17736-17739	and	_
101-41	17740-17743	the	_
101-42	17744-17753	precision	_
101-43	17754-17763	parameter	_
101-44	17764-17765	γ	_
101-45	17766-17767	⊂	_
101-46	17768-17769	θ	_
101-47	17770-17771	(	_
101-48	17772-17773	2	_
101-49	17774-17775	)	_
101-50	17776-17782	scales	_
101-51	17783-17784	a	_
101-52	17785-17794	precision	_
101-53	17795-17804	component	_
101-54	17805-17807	Q1	_
101-55	17808-17809	.	_

102-1	17810-17814	Here	_
102-2	17815-17816	,	_
102-3	17817-17819	we	_
102-4	17820-17824	used	_
102-5	17825-17828	the	_
102-6	17829-17837	defaults	_
102-7	17838-17840	in	_
102-8	17841-17844	SPM	_
102-9	17845-17846	,	_
102-10	17847-17852	which	_
102-11	17853-17857	sets	_
102-12	17858-17860	Q1	_
102-13	17861-17863	to	_
102-14	17864-17865	,	_
102-15	17866-17871	where	_
102-16	17872-17874	pC	_
102-17	17875-17877	is	_
102-18	17878-17881	the	_
102-19	17882-17887	prior	_
102-20	17888-17898	covariance	_
102-21	17899-17905	matrix	_
102-22	17906-17908	of	_
102-23	17909-17910	a	_
102-24	17911-17917	single	_
102-25	17918-17925	subject	_
102-26	17926-17928	's	_
102-27	17929-17932	DCM	_
102-28	17933-17943	parameters	_
102-29	17944-17947	and	_
102-30	17948-17949	β	_
102-31	17950-17951	=	_
102-32	17952-17954	16	_
102-33	17955-17956	.	_

103-1	17957-17959	To	_
103-2	17960-17969	summarize	_
103-3	17970-17971	,	_
103-4	17972-17975	the	_
103-5	17976-17979	PEB	_
103-6	17980-17985	model	_
103-7	17986-17995	estimates	_
103-8	17996-17999	the	_
103-9	18000-18006	effect	_
103-10	18007-18009	of	_
103-11	18010-18014	each	_
103-12	18015-18024	covariate	_
103-13	18025-18027	on	_
103-14	18028-18032	each	_
103-15	18033-18043	connection	_
103-16	18044-18045	(	_
103-17	18046-18050	both	_
103-18	18051-18054	the	_
103-19	18055-18060	group	_
103-20	18061-18065	mean	_
103-21	18066-18069	and	_
103-22	18070-18073	any	_
103-23	18074-18079	group	_
103-24	18080-18091	differences	_
103-25	18092-18093	)	_
103-26	18094-18095	,	_
103-27	18096-18098	as	_
103-28	18099-18103	well	_
103-29	18104-18106	as	_
103-30	18107-18117	estimating	_
103-31	18118-18121	the	_
103-32	18122-18137	between-subject	_
103-33	18138-18149	variability	_
103-34	18150-18151	.	_

104-1	18152-18155	The	_
104-2	18156-18166	parameters	_
104-3	18167-18169	of	_
104-4	18170-18173	the	_
104-5	18174-18177	PEB	_
104-6	18178-18183	model	_
104-7	18184-18188	were	_
104-8	18189-18198	estimated	_
104-9	18199-18204	using	_
104-10	18205-18206	a	_
104-11	18207-18215	standard	_
104-12	18216-18227	variational	_
104-13	18228-18235	Laplace	_
104-14	18236-18245	procedure	_
104-15	18246-18247	,	_
104-16	18248-18250	as	_
104-17	18251-18253	is	_
104-18	18254-18261	usually	_
104-19	18262-18269	applied	_
104-20	18270-18272	in	_
104-21	18273-18276	DCM	_
104-22	18277-18278	.	_

105-1	18279-18287	Bayesian	_
105-2	18288-18293	model	_
105-3	18294-18303	reduction	_
105-4	18304-18306	To	_
105-5	18307-18315	evaluate	_
105-6	18316-18319	how	_
105-7	18320-18323	the	_
105-8	18324-18336	connectivity	_
105-9	18337-18339	of	_
105-10	18340-18348	patients	_
105-11	18349-18353	with	_
105-12	18354-18367	schizophrenia	_
105-13	18368-18375	differs	_
105-14	18376-18380	from	_
105-15	18381-18385	that	_
105-16	18386-18388	of	_
105-17	18389-18395	normal	_
105-18	18396-18404	controls	_
105-19	18405-18406	,	_
105-20	18407-18409	we	_
105-21	18410-18414	used	_
105-22	18415-18423	Bayesian	_
105-23	18424-18429	model	_
105-24	18430-18440	comparison	_
105-25	18441-18443	to	_
105-26	18444-18451	explore	_
105-27	18452-18455	the	_
105-28	18456-18461	space	_
105-29	18462-18464	of	_
105-30	18465-18473	possible	_
105-31	18474-18484	hypotheses	_
105-32	18485-18486	(	_
105-33	18487-18493	models	_
105-34	18494-18495	)	_
105-35	18496-18497	,	_
105-36	18498-18503	where	_
105-37	18504-18508	each	_
105-38	18509-18519	hypothesis	_
105-39	18520-18522	or	_
105-40	18523-18528	model	_
105-41	18529-18536	assumes	_
105-42	18537-18541	that	_
105-43	18542-18543	a	_
105-44	18544-18553	different	_
105-45	18554-18565	combination	_
105-46	18566-18568	of	_
105-47	18569-18572	the	_
105-48	18573-18584	connections	_
105-49	18585-18590	could	_
105-50	18591-18596	exist	_
105-51	18597-18603	across	_
105-52	18604-18616	participants	_
105-53	18617-18619	or	_
105-54	18620-18624	show	_
105-55	18625-18635	phenotypic	_
105-56	18636-18644	variance	_
105-57	18645-18646	.	_

106-1	18647-18656	Candidate	_
106-2	18657-18660	PEB	_
106-3	18661-18667	models	_
106-4	18668-18672	were	_
106-5	18673-18681	obtained	_
106-6	18682-18684	by	_
106-7	18685-18693	removing	_
106-8	18694-18697	one	_
106-9	18698-18700	or	_
106-10	18701-18705	more	_
106-11	18706-18707	(	_
106-12	18708-18714	second	_
106-13	18715-18720	level	_
106-14	18721-18722	)	_
106-15	18723-18733	parameters	_
106-16	18734-18738	from	_
106-17	18739-18742	the	_
106-18	18743-18747	full	_
106-19	18748-18751	PEB	_
106-20	18752-18757	model	_
106-21	18758-18759	(	_
106-22	18760-18769	described	_
106-23	18770-18775	above	_
106-24	18776-18777	)	_
106-25	18778-18780	to	_
106-26	18781-18788	produce	_
106-27	18789-18796	reduced	_
106-28	18797-18802	forms	_
106-29	18803-18805	of	_
106-30	18806-18809	the	_
106-31	18810-18814	full	_
106-32	18815-18820	model	_
106-33	18821-18825	that	_
106-34	18826-18834	differed	_
106-35	18835-18839	only	_
106-36	18840-18842	in	_
106-37	18843-18848	their	_
106-38	18849-18855	priors	_
106-39	18856-18857	.	_

107-1	18858-18860	We	_
107-2	18861-18864	did	_
107-3	18865-18869	this	_
107-4	18870-18875	using	_
107-5	18876-18884	Bayesian	_
107-6	18885-18890	model	_
107-7	18891-18900	reduction	_
107-8	18901-18902	(	_
107-9	18903-18906	BMR	_
107-10	18907-18908	)	_
107-11	18909-18913	that	_
107-12	18914-18921	enables	_
107-13	18922-18925	the	_
107-14	18926-18934	evidence	_
107-15	18935-18938	and	_
107-16	18939-18949	parameters	_
107-17	18950-18952	of	_
107-18	18953-18959	nested	_
107-19	18960-18961	(	_
107-20	18962-18969	reduced	_
107-21	18970-18971	)	_
107-22	18972-18978	models	_
107-23	18979-18981	to	_
107-24	18982-18984	be	_
107-25	18985-18992	derived	_
107-26	18993-19001	directly	_
107-27	19002-19006	from	_
107-28	19007-19008	a	_
107-29	19009-19013	full	_
107-30	19014-19019	model	_
107-31	19020-19021	.	_

108-1	19022-19026	This	_
108-2	19027-19035	provides	_
108-3	19036-19038	an	_
108-4	19039-19048	efficient	_
108-5	19049-19055	search	_
108-6	19056-19058	of	_
108-7	19059-19062	the	_
108-8	19063-19068	model	_
108-9	19069-19074	space	_
108-10	19075-19077	by	_
108-11	19078-19085	scoring	_
108-12	19086-19090	each	_
108-13	19091-19098	reduced	_
108-14	19099-19104	model	_
108-15	19105-19106	,	_
108-16	19107-19112	based	_
108-17	19113-19115	on	_
108-18	19116-19119	its	_
108-19	19120-19123	log	_
108-20	19124-19138	model-evidence	_
108-21	19139-19141	or	_
108-22	19142-19146	free	_
108-23	19147-19153	energy	_
108-24	19154-19155	;	_
108-25	19156-19159	for	_
108-26	19160-19167	details	_
108-27	19168-19169	,	_
108-28	19170-19173	see	_
108-29	19174-19175	.	_

109-1	19176-19179	The	_
109-2	19180-19181	(	_
109-3	19182-19188	greedy	_
109-4	19189-19190	)	_
109-5	19191-19197	search	_
109-6	19198-19207	algorithm	_
109-7	19208-19212	used	_
109-8	19213-19216	BMR	_
109-9	19217-19219	to	_
109-10	19220-19231	iteratively	_
109-11	19232-19237	prune	_
109-12	19238-19248	connection	_
109-13	19249-19259	parameters	_
109-14	19260-19264	from	_
109-15	19265-19268	the	_
109-16	19269-19273	full	_
109-17	19274-19277	PEB	_
109-18	19278-19283	model	_
109-19	19284-19285	,	_
109-20	19286-19291	until	_
109-21	19292-19306	model-evidence	_
109-22	19307-19314	started	_
109-23	19315-19317	to	_
109-24	19318-19326	decrease	_
109-25	19327-19328	.	_

110-1	19329-19332	The	_
110-2	19333-19343	parameters	_
110-3	19344-19346	of	_
110-4	19347-19350	the	_
110-5	19351-19355	best	_
110-6	19356-19359	256	_
110-7	19360-19366	pruned	_
110-8	19367-19373	models	_
110-9	19374-19378	were	_
110-10	19379-19383	then	_
110-11	19384-19392	averaged	_
110-12	19393-19394	,	_
110-13	19395-19403	weighted	_
110-14	19404-19406	by	_
110-15	19407-19412	their	_
110-16	19413-19421	evidence	_
110-17	19422-19423	(	_
110-18	19424-19432	Bayesian	_
110-19	19433-19438	Model	_
110-20	19439-19448	Averaging	_
110-21	19449-19450	)	_
110-22	19451-19452	.	_

111-1	19453-19455	To	_
111-2	19456-19465	summarize	_
111-3	19466-19469	the	_
111-4	19470-19473	DCM	_
111-5	19474-19482	analysis	_
111-6	19483-19491	pipeline	_
111-7	19492-19493	,	_
111-8	19494-19496	we	_
111-9	19497-19502	first	_
111-10	19503-19512	specified	_
111-11	19513-19514	a	_
111-12	19515-19518	DCM	_
111-13	19519-19522	for	_
111-14	19523-19527	each	_
111-15	19528-19535	subject	_
111-16	19536-19539	and	_
111-17	19540-19546	fitted	_
111-18	19547-19549	it	_
111-19	19550-19552	to	_
111-20	19553-19558	their	_
111-21	19559-19563	data	_
111-22	19564-19565	,	_
111-23	19566-19575	providing	_
111-24	19576-19585	estimates	_
111-25	19586-19588	of	_
111-26	19589-19592	the	_
111-27	19593-19605	connectivity	_
111-28	19606-19616	parameters	_
111-29	19617-19618	.	_

112-1	19619-19624	These	_
112-2	19625-19641	subject-specific	_
112-3	19642-19651	estimates	_
112-4	19652-19653	(	_
112-5	19654-19662	expected	_
112-6	19663-19669	values	_
112-7	19670-19673	and	_
112-8	19674-19684	covariance	_
112-9	19685-19686	)	_
112-10	19687-19691	were	_
112-11	19692-19697	taken	_
112-12	19698-19700	to	_
112-13	19701-19704	the	_
112-14	19705-19710	group	_
112-15	19711-19716	level	_
112-16	19717-19720	and	_
112-17	19721-19728	modeled	_
112-18	19729-19734	using	_
112-19	19735-19736	a	_
112-20	19737-19745	Bayesian	_
112-21	19746-19749	GLM	_
112-22	19750-19751	(	_
112-23	19752-19756	i.e.	_
112-24	19757-19758	,	_
112-25	19759-19760	a	_
112-26	19761-19764	PEB	_
112-27	19765-19770	model	_
112-28	19771-19772	)	_
112-29	19773-19774	.	_

113-1	19775-19778	The	_
113-2	19779-19789	parameters	_
113-3	19790-19792	of	_
113-4	19793-19796	the	_
113-5	19797-19800	GLM	_
113-6	19801-19810	represent	_
113-7	19811-19814	the	_
113-8	19815-19820	group	_
113-9	19821-19828	average	_
113-10	19829-19831	of	_
113-11	19832-19836	each	_
113-12	19837-19849	connectivity	_
113-13	19850-19859	parameter	_
113-14	19860-19861	,	_
113-15	19862-19864	as	_
113-16	19865-19869	well	_
113-17	19870-19872	as	_
113-18	19873-19876	any	_
113-19	19877-19882	group	_
113-20	19883-19894	differences	_
113-21	19895-19902	between	_
113-22	19903-19911	patients	_
113-23	19912-19915	and	_
113-24	19916-19924	controls	_
113-25	19925-19926	.	_

114-1	19927-19929	We	_
114-2	19930-19934	than	_
114-3	19935-19939	used	_
114-4	19940-19948	Bayesian	_
114-5	19949-19954	model	_
114-6	19955-19964	reduction	_
114-7	19965-19967	to	_
114-8	19968-19974	search	_
114-9	19975-19979	over	_
114-10	19980-19988	hundreds	_
114-11	19989-19991	of	_
114-12	19992-19999	reduced	_
114-13	20000-20003	PEB	_
114-14	20004-20010	models	_
114-15	20011-20015	with	_
114-16	20016-20025	different	_
114-17	20026-20038	combinations	_
114-18	20039-20041	of	_
114-19	20042-20053	connections	_
114-20	20054-20055	(	_
114-21	20056-20059	and	_
114-22	20060-20065	group	_
114-23	20066-20077	differences	_
114-24	20078-20079	)	_
114-25	20080-20081	.	_

115-1	20082-20085	The	_
115-2	20086-20090	best	_
115-3	20091-20097	models	_
115-4	20098-20102	from	_
115-5	20103-20107	this	_
115-6	20108-20114	search	_
115-7	20115-20119	were	_
115-8	20120-20128	combined	_
115-9	20129-20134	using	_
115-10	20135-20143	Bayesian	_
115-11	20144-20149	model	_
115-12	20150-20159	averaging	_
115-13	20160-20161	.	_

116-1	20162-20164	We	_
116-2	20165-20171	report	_
116-3	20172-20177	these	_
116-4	20178-20186	averages	_
116-5	20187-20189	in	_
116-6	20190-20193	the	_
116-7	20194-20201	Results	_
116-8	20202-20209	section	_
116-9	20210-20211	.	_

117-1	20212-20220	Clinical	_
117-2	20221-20231	correlates	_
117-3	20232-20234	of	_
117-4	20235-20249	differentiated	_
117-5	20250-20261	connections	_
117-6	20262-20268	Having	_
117-7	20269-20279	identified	_
117-8	20280-20283	the	_
117-9	20284-20295	connections	_
117-10	20296-20300	that	_
117-11	20301-20309	differed	_
117-12	20310-20317	between	_
117-13	20318-20326	patients	_
117-14	20327-20330	and	_
117-15	20331-20339	controls	_
117-16	20340-20342	in	_
117-17	20343-20346	the	_
117-18	20347-20354	working	_
117-19	20355-20361	memory	_
117-20	20362-20366	task	_
117-21	20367-20368	,	_
117-22	20369-20371	we	_
117-23	20372-20376	next	_
117-24	20377-20382	asked	_
117-25	20383-20390	whether	_
117-26	20391-20394	the	_
117-27	20395-20403	strength	_
117-28	20404-20406	of	_
117-29	20407-20412	these	_
117-30	20413-20424	connections	_
117-31	20425-20435	correlated	_
117-32	20436-20440	with	_
117-33	20441-20444	the	_
117-34	20445-20453	severity	_
117-35	20454-20456	of	_
117-36	20457-20465	symptoms	_
117-37	20466-20468	in	_
117-38	20469-20477	patients	_
117-39	20478-20479	.	_

118-1	20480-20482	As	_
118-2	20483-20485	we	_
118-3	20486-20489	had	_
118-4	20490-20491	a	_
118-5	20492-20497	large	_
118-6	20498-20504	number	_
118-7	20505-20507	of	_
118-8	20508-20517	variables	_
118-9	20518-20519	,	_
118-10	20520-20522	we	_
118-11	20523-20526	did	_
118-12	20527-20530	not	_
118-13	20531-20538	include	_
118-14	20539-20544	these	_
118-15	20545-20547	in	_
118-16	20548-20551	the	_
118-17	20552-20555	PEB	_
118-18	20556-20561	model	_
118-19	20562-20570	directly	_
118-20	20571-20572	;	_
118-21	20573-20580	instead	_
118-22	20581-20582	,	_
118-23	20583-20585	we	_
118-24	20586-20590	used	_
118-25	20591-20592	a	_
118-26	20593-20594	(	_
118-27	20595-20599	post	_
118-28	20600-20603	hoc	_
118-29	20604-20605	)	_
118-30	20606-20615	canonical	_
118-31	20616-20624	variates	_
118-32	20625-20633	analysis	_
118-33	20634-20635	(	_
118-34	20636-20639	CVA	_
118-35	20640-20641	)	_
118-36	20642-20644	to	_
118-37	20645-20653	identify	_
118-38	20654-20660	linear	_
118-39	20661-20674	relationships	_
118-40	20675-20682	between	_
118-41	20683-20686	the	_
118-42	20687-20690	two	_
118-43	20691-20695	sets	_
118-44	20696-20698	of	_
118-45	20699-20707	measures	_
118-46	20708-20709	(	_
118-47	20710-20718	strength	_
118-48	20719-20721	of	_
118-49	20722-20731	effective	_
118-50	20732-20744	connectivity	_
118-51	20745-20748	and	_
118-52	20749-20757	clinical	_
118-53	20758-20766	symptoms	_
118-54	20767-20768	)	_
118-55	20769-20770	.	_

119-1	20771-20775	This	_
119-2	20776-20784	resulted	_
119-3	20785-20787	in	_
119-4	20788-20793	pairs	_
119-5	20794-20796	of	_
119-6	20797-20810	significantly	_
119-7	20811-20821	correlated	_
119-8	20822-20831	canonical	_
119-9	20832-20841	variables	_
119-10	20842-20843	(	_
119-11	20844-20848	i.e.	_
119-12	20849-20850	,	_
119-13	20851-20857	latent	_
119-14	20858-20870	connectivity	_
119-15	20871-20874	and	_
119-16	20875-20882	symptom	_
119-17	20883-20891	profiles	_
119-18	20892-20893	)	_
119-19	20894-20895	.	_

120-1	20896-20901	Using	_
120-2	20902-20905	the	_
120-3	20906-20910	same	_
120-4	20911-20919	analysis	_
120-5	20920-20921	,	_
120-6	20922-20924	we	_
120-7	20925-20930	asked	_
120-8	20931-20938	whether	_
120-9	20939-20942	our	_
120-10	20943-20952	cognitive	_
120-11	20953-20959	scores	_
120-12	20960-20965	could	_
120-13	20966-20968	be	_
120-14	20969-20978	predicted	_
120-15	20979-20981	by	_
120-16	20982-20985	the	_
120-17	20986-20995	effective	_
120-18	20996-21008	connectivity	_
120-19	21009-21010	.	_

121-1	21011-21017	Effect	_
121-2	21018-21020	of	_
121-3	21021-21034	antipsychotic	_
121-4	21035-21045	medication	_
121-5	21046-21048	In	_
121-6	21049-21054	order	_
121-7	21055-21057	to	_
121-8	21058-21068	ameliorate	_
121-9	21069-21072	the	_
121-10	21073-21084	confounding	_
121-11	21085-21091	effect	_
121-12	21092-21094	of	_
121-13	21095-21108	antipsychotic	_
121-14	21109-21119	medication	_
121-15	21120-21122	on	_
121-16	21123-21128	group	_
121-17	21129-21140	differences	_
121-18	21141-21142	,	_
121-19	21143-21145	we	_
121-20	21146-21154	included	_
121-21	21155-21158	the	_
121-22	21159-21173	chlorpromazine	_
121-23	21174-21185	equivalents	_
121-24	21186-21188	of	_
121-25	21189-21202	antipsychotic	_
121-26	21203-21213	medication	_
121-27	21214-21216	as	_
121-28	21217-21218	a	_
121-29	21219-21227	nuisance	_
121-30	21228-21237	covariate	_
121-31	21238-21239	–	_
121-32	21240-21242	in	_
121-33	21243-21251	addition	_
121-34	21252-21254	to	_
121-35	21255-21258	the	_
121-36	21259-21267	nuisance	_
121-37	21268-21278	covariates	_
121-38	21279-21284	above	_
121-39	21285-21286	(	_
121-40	21287-21294	working	_
121-41	21295-21301	memory	_
121-42	21302-21313	performance	_
121-43	21314-21317	and	_
121-44	21318-21329	interaction	_
121-45	21330-21337	between	_
121-46	21338-21347	diagnosis	_
121-47	21348-21351	and	_
121-48	21352-21363	performance	_
121-49	21364-21365	)	_
121-50	21366-21367	–	_
121-51	21368-21370	in	_
121-52	21371-21374	the	_
121-53	21375-21382	between	_
121-54	21383-21390	subject	_
121-55	21391-21397	design	_
121-56	21398-21404	matrix	_
121-57	21405-21406	.	_

122-1	21407-21410	The	_
122-2	21411-21415	main	_
122-3	21416-21423	effects	_
122-4	21424-21426	of	_
122-5	21427-21432	group	_
122-6	21433-21437	were	_
122-7	21438-21447	unchanged	_
122-8	21448-21452	when	_
122-9	21453-21462	including	_
122-10	21463-21476	antipsychotic	_
122-11	21477-21487	medication	_
122-12	21488-21490	as	_
122-13	21491-21492	a	_
122-14	21493-21500	between	_
122-15	21501-21508	subject	_
122-16	21509-21515	effect	_
122-17	21516-21517	.	_

123-1	21518-21520	We	_
123-2	21521-21528	present	_
123-3	21529-21532	the	_
123-4	21533-21539	effect	_
123-5	21540-21542	of	_
123-6	21543-21546	the	_
123-7	21547-21560	antipsychotic	_
123-8	21561-21571	medication	_
123-9	21572-21575	and	_
123-10	21576-21581	other	_
123-11	21582-21590	nuisance	_
123-12	21591-21601	covariates	_
123-13	21602-21604	on	_
123-14	21605-21614	effective	_
123-15	21615-21627	connectivity	_
123-16	21628-21630	in	_
123-17	21631-21634	the	_
123-18	21635-21648	supplementary	_
123-19	21649-21658	materials	_
123-20	21659-21660	(	_
123-21	21661-21664	Fig	_
123-22	21665-21666	.	_

124-1	21667-21669	S1	_
124-2	21670-21671	)	_
124-3	21672-21673	.	_

125-1	21674-21676	We	_
125-2	21677-21681	also	_
125-3	21682-21689	include	_
125-4	21690-21693	the	_
125-5	21694-21708	chlorpromazine	_
125-6	21709-21720	equivalents	_
125-7	21721-21723	of	_
125-8	21724-21737	antipsychotic	_
125-9	21738-21748	medication	_
125-10	21749-21753	into	_
125-11	21754-21757	the	_
125-12	21758-21761	CVA	_
125-13	21762-21768	models	_
125-14	21769-21774	while	_
125-15	21775-21784	exploring	_
125-16	21785-21788	the	_
125-17	21789-21797	clinical	_
125-18	21798-21808	correlates	_
125-19	21809-21811	of	_
125-20	21812-21825	differentiate	_
125-21	21826-21837	connections	_
125-22	21838-21839	.	_

